CN113249469A - Clonal eosinophilia hypereosinophilia fusion gene detection probe composition, kit and application thereof - Google Patents

Clonal eosinophilia hypereosinophilia fusion gene detection probe composition, kit and application thereof Download PDF

Info

Publication number
CN113249469A
CN113249469A CN202110754789.XA CN202110754789A CN113249469A CN 113249469 A CN113249469 A CN 113249469A CN 202110754789 A CN202110754789 A CN 202110754789A CN 113249469 A CN113249469 A CN 113249469A
Authority
CN
China
Prior art keywords
dna
artificial synthesis
pdgfrb
pdgfrfgfr
fusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110754789.XA
Other languages
Chinese (zh)
Other versions
CN113249469B (en
Inventor
顾凯丽
陆亚红
邓啸
张亚飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meijie Transformation Medical Research Suzhou Co ltd
Original Assignee
Meijie Transformation Medical Research Suzhou Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meijie Transformation Medical Research Suzhou Co ltd filed Critical Meijie Transformation Medical Research Suzhou Co ltd
Priority to CN202110754789.XA priority Critical patent/CN113249469B/en
Publication of CN113249469A publication Critical patent/CN113249469A/en
Application granted granted Critical
Publication of CN113249469B publication Critical patent/CN113249469B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/1013Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by using magnetic beads
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention provides a clonal eosinophilia hypereosinophilia fusion gene detection probe composition, a kit and application thereof. The invention firstly classifies the related fusion genes, wherein the clonal eosinophilia-mediated polycythemia fusion detection core genes FGFR1, PDGFRA and PDGFRB are I-class genes, so the full length of the gene transcript is taken as a target region; the other genes are class II genes, and only the fragment near the fusion breakpoint is used as the target region. According to the base complementary pairing principle, a complementary sequence of a target region is designed to serve as a probe to form a liquid phase chip, the probe relates to 39 target genes, the eosinophilia fusion gene is detected by capturing the corresponding target sequence in a transcriptome library and combining high-throughput sequencing, multiple fusions can be detected at one time, the capability of finding new fusions is realized, the detection cost is reduced, and the accuracy of the detection result is improved.

Description

Clonal eosinophilia hypereosinophilia fusion gene detection probe composition, kit and application thereof
Technical Field
The invention belongs to the technical field of liquid phase capture and the technical field of transcriptome sequencing analysis, and relates to a clonal eosinophilia-mediated granulocytopenia fusion gene detection probe composition, a kit and application thereof.
Background
Eosinophilia (Eosinophilia) refers to a group of diseases with Eosinophilia or tissue damage in peripheral blood, usually higher than 0.5 × 10 in absolute counts9The term,/L, is used. If the peripheral blood eosinophil count is higher than 1.5X 109the/L, i.e. whether or not there is organ damage, is called hypereosinophia syndrome (HE). Wherein the number of eosinophils is 1.5 to 5X 109the/L, referred to as moderate boost,>5×109the/L is called the heaviness increase. Eosinophilia syndrome can be classified into four categories according to the etiology: reactive hypereosinophilia, secondary hypereosinophilia, idiopathic hypereosinophilia, and clonal hypereosinophilia.
Wherein, the clonal eosinophilia disease refers to eosinophil originated from blood tumor clone, which mainly comprises: the marrow-line and gonorrhoea-line tumors are accompanied by PDGFRA, PDGFRB, FGFR1 rearrangement or PCM1-JAK2, ETV6-JAK2 or BCR-JAK2 fusion genes; ② chronic eosinophilic leukemia-nonspecific (CEL-NOS), including chaperone ETV6-ABL1, ETV6-FLT3 or other kinase fusion genes; ③ atypical chronic myelogenous leukemia with eosinophilia (aCML-Eo); chronic myelomonocytic leukemia with eosinophilia (CMML-Eo); chronic myelogenous leukemia in accelerated or acute phase (occasionally); sixthly, other myeloproliferative tumors in the acute stage (occasionally); seventhly, acute myeloid leukemia with eosinophilia (AML-Eo), especially with t (8; 21) (q 22; q 22) or inv (16) (p13.1q22) (only occasionally); acute lymphoblastic leukemia, if it is proved that the eosinophilic granulocyte comes from malignant clone; ninthly systemic mastocytosis (eosinophils proved to be clonal).
For patients with clonal eosinophilia, accurate detection of the relevant fusion is of great significance for assisting in identifying the disease type of the patients and guiding clinical treatment. As positive for the FIP1L1-PDGFRA gene (including patients presenting with acute leukemia), a small dose of imatinib is recommended; positive for the presence of PDGFRB gene rearrangement or ETV6-ABL1 fusion gene, standard dose imatinib is recommended; the ETV6-FLT3 fusion gene exists, and sunitinib or sorafenib is recommended; presence of JAK2 gene rearrangement: luccotinib treatment is one of the options.
In addition, with regard to clonal HE caused by the myeloid and lymphoid tumors with PDGFRA, PDGFRB, FGFR1 rearrangement or PCM1-JAK2, ETV6-JAK2 or BCR-JAK2 fusion genes, the potential fusions caused by PDGFRA, PDGFRB and FGFR1 rearrangement are very diverse, and only by way of example with PDGFRB, the PDGFRB fusions related to eosinophilia which have been found so far have approached 20, and there may be new fusion types which have not been found so far. Therefore, the fusion screening method which is comprehensive and accurate and simultaneously needs to have new fusion discovery capability plays a crucial role in the auxiliary diagnosis and medication guidance of the clonal eosinophilia.
At present, the mainstream clinical fusion gene screening methods mainly comprise a second-generation transcriptome double-end sequencing method and a multiple PCR method. Double-end sequencing (pair-end sequencing), namely, fixed-length reads (reads) are respectively and initially detected at two ends of a sequencing library, the sequencing reads at the two ends form a pair, the reads are returned to a genome, and the returned positions of the paired reads on the genome are used for judging whether fusion is supported. The method can screen all fusion events in the transcriptome at one time, but because the expressed genes in the transcriptome are more than ten thousand, and the expression level of some housekeeping genes (house-eating genes) is extremely high, the fusion transcripts with lower expression level are difficult to detect under the condition of limited sequencing amount, thus easily causing false negative and misleading diagnosis or treatment. On the other hand, the transcriptome itself is very large, and the data volume based on the next generation sequencing is very large, which means that the cost of fusion analysis is very high, and the popularization and application of the fusion analysis in clinic are prevented.
The fusion screening by the multiplex PCR method is easy to be clinically applied at present, and the working principle is that a plurality of pairs of primers are added into the same reaction system, and a plurality of fused DNA fragments are amplified simultaneously. The method is economic, simple and convenient and high in sensitivity, but for different fusions, primers need to be independently debugged to enable the fusions to work in the same system, new fusions cannot be flexibly added, and the expandability is poor. In addition, the method mainly aims at detecting the known fusion, and does not have the capability of discovering new fusion, thereby possibly leading to the omission of some new fusions. And at present, a device for detecting clonal eosinophilia by a multiplex PCR method has not been used temporarily.
Therefore, a method for detecting a clonal hypereosinophilia fusion gene, which is comprehensive, has higher sensitivity, strong expandability and certain new fusion discovery capability, is needed.
Disclosure of Invention
Aiming at the defects and actual requirements of the prior art, the invention provides a clonal eosinophilia-associated hypereosinophilia fusion gene detection probe composition, a kit and application thereof, wherein the related fusion gene is detected by combining liquid phase capture and second-generation transcriptome sequencing, the detection cost of the fusion gene is reduced, the result accuracy is improved, and the clonal eosinophilia-associated hypereosinophilia fusion gene detection probe composition has certain new fusion discovery capability.
In order to achieve the purpose, the invention adopts the following technical scheme:
in a first aspect, the present invention provides a detection probe composition for eosinophilia fusion gene, wherein a target gene of the detection probe composition comprises a class I gene and a class II gene;
the target region of the detection probe composition is the full length of the transcript of the class I gene and the region near the fusion breakpoint of the class II gene;
the class I genes include FGFR1, PDGFRA and PDGFRB;
the class II genes include ABL1, BCR, CCDC88C, CDK5RAP2, CEP110, CEP85L, CPSF6, CUX1, DTD1, ETV6, FGFR1OP1, FGFR1OP2, FIP1L1, FLT3, GIT2, GOLGA4, HIP1, JAK2, KANK1, KIF5B, LRRFIP1, MYO18A, NDE1, NIN, PCM1, PDE4DIP, PRKG2, RABEP1, cc1, STRN, TPM3, TPR, TP53BP1, TRIM24, WDR48, and ZNF 198.
In the invention, firstly, the related fusion genes are divided into two types according to the clinical diagnosis and treatment background of the clonal eosinophilia. Wherein, the cloned eosinophilia polycythemia lipolytica fusion detection core genes FGFR1, PDGFRA and PDGFRB are I-class genes, so the full length of the gene transcript is used as a target region; the other genes are class II genes, and only the vicinity of the fusion break point is used as a target region.
The fusion breakpoint vicinity region in the invention can be a region within 100-300 bp of the fusion breakpoint vicinity, and preferably a region around 200 bp of the fusion breakpoint.
The target genes of the detection probe composition are shown in the following table 1:
Figure 133845DEST_PATH_IMAGE001
the fusion genes detected by the detection probe composition are shown in the following table 2:
Figure 598324DEST_PATH_IMAGE002
preferably, the detection probe composition comprises a nucleic acid sequence shown in SEQ ID number 1-310.
According to the base complementary pairing principle, a complementary sequence of a target region is designed to be used as a probe, and all the probes are dissolved in an IDTE solution to form a liquid phase chip.
Preferably, the probes in the detection probe composition are modified with a labeling molecule I, which may be biotin.
In the invention, the probe exists in a liquid phase, and by carrying a biotin label, the streptavidin magnetic bead can be used for adsorbing the probe and a target region combined with the probe, then denaturation treatment is carried out to separate the probe from the target region, and the magnetic bead is used for absorbing and discarding the probe, thereby realizing capture and enrichment of the target region.
In a second aspect, the present invention provides a kit for detecting a clonal eosinophilia-mediated fusion gene, wherein the kit comprises the detection probe composition of the first aspect.
Preferably, the detection kit further comprises any one or a combination of at least two of a reverse transcription reagent, a sequencing library construction reagent, a PCR reagent or a probe hybridization reagent.
Preferably, the reverse transcription reagent comprises a single-stranded cDNA synthetase and/or a double-stranded cDNA synthetase.
Preferably, the sequencing library building reagent comprises any one of or a combination of at least two of an RNA fragmentation enzyme, a terminal-plus-a tailase, a ligase, or a linker.
Preferably, the PCR reagents comprise a DNA polymerase and/or PCR primers.
Preferably, the probe hybridization reagent comprises a hybridization buffer and/or an rnase inhibitor.
Preferably, the detection kit further comprises a nucleic acid purification reagent.
Preferably, the nucleic acid purification reagent comprises magnetic beads and/or a washing solution.
Preferably, the magnetic beads are modified with a labeling molecule II, and the labeling molecule I can be combined with the labeling molecule II, for example, the magnetic beads can be streptavidin magnetic beads;
it should be noted that, the specific types of the labeling molecules I and II are not limited in the present invention, and only the labeling molecules I and II can be combined with each other, i.e., the biotin and streptavidin magnetic bead system is used in the present invention.
In a third aspect, the present invention provides a method for detecting a clonal hypereosinophilia-associated fusion gene for the purpose of non-disease diagnosis, comprising the following steps:
extracting total RNA in a sample, carrying out mRNA enrichment by using magnetic beads, carrying out thermal interruption on the enriched RNA, carrying out reverse transcription on the RNA into cDNA, carrying out terminal repair, adding A tail, connecting a joint and PCR amplification, and constructing a pre-library; hybridizing a capture target fragment from the pre-library by using the detection probe composition of the first aspect, performing PCR amplification, and constructing a probe capture transcriptome library; and sequencing and data processing the probe-captured transcriptome library, and analyzing the cloned eosinophilia-related fusion gene.
In the present invention, the method for detecting clonal eosinophilia-mediated fusion gene based on targeted capture of transcriptome library is shown in FIG. 1:
(1) designing a probe: designing a detection probe composition aiming at the class I gene and the class II gene; (2) constructing an expression transcript library; (3) enriching target genes: capturing a target gene by using the detection probe composition, eluting non-target cDNA, and purifying to obtain target cDNA; (4) sequencing; (5) and (6) analyzing.
Preferably, the reverse transcription comprises one-strand cDNA synthesis and two-strand cDNA synthesis.
Preferably, the conditions for the single-stranded cDNA synthesis are: taking the fragmented RNA as a template, adding components required by one-strand synthesis, and carrying out total reaction of 25 μ L (hot cover 105 ℃, 25 ℃ for 10min, 42 ℃ for 15min, 70 ℃ for 15min, 4 ℃ hold);
preferably, the conditions for the two-strand cDNA synthesis are: using the single-stranded cDNA as a template, 65. mu.L of the total reaction system (hot lid 105 ℃, 16 ℃ for 30 min, 65 ℃ for 15min, 4 ℃ hold) was prepared.
Preferably, the sequencing of the capture transcriptome library is performed in a paired-end sequencing mode, and the data processing comprises:
(1) aligning the read obtained by sequencing to a reference genome, and screening the read which cannot be completely matched with a single gene as a candidate fusion gene sequence, wherein the candidate fusion gene sequence comprises joint reads (Junction reads) and cross-breakpoint reads (bridging reads) as shown in FIG. 2;
(2) comparing the candidate fusion gene sequence with a reference genome annotation file, and predicting the fusion gene according to the overlapping condition of the reading sequence;
(3) and performing correction analysis according to the minimum reading support criterion and a checking tool, filtering a prediction result, and removing false positive fusion.
In the present invention, the conditions for determining the final positive fusion gene are: the sum of the numbers of the supported binding reading sequences and cross breakpoint reading sequences of the candidate fusion genes after the data processing is not less than 4.
In a fourth aspect, the present invention provides a detecting apparatus for a clonal hypereosinophilia-associated fusion gene, comprising:
a nucleic acid extraction module: for extracting RNA from a clonal eosinophilia sample;
a reverse transcription module: for reverse transcription of the extracted RNA into cDNA;
pre-library construction module: the method is used for carrying out terminal repair, A tail addition, linker connection and PCR amplification on the reverse transcription cDNA to construct a pre-library;
a hybrid capture module: capturing a target fragment from a pre-library by using the detection probe composition of the first aspect, and performing PCR amplification to construct a probe capture library;
a sequencing module: for sequencing and data processing of the probe capture library.
In a fifth aspect, the invention provides a use of the detection probe composition of the first aspect, the detection kit of the second aspect or the detection apparatus of the fourth aspect in the preparation of a diagnostic product for clonal hypereosinophilia.
Compared with the prior art, the invention has the following beneficial effects:
the invention provides a detecting probe composition for eosinophilia fusion genes, which takes clonal eosinophilia fusion detection core genes FGFR1, PDGFRA and PDGFRB as class I genes, takes the full length of a transcript of the class I gene and the area near the fusion end point of the class II gene as target areas respectively, and takes the gene as a gene carrier of the class II genes; the cloned eosinophilia fusion gene is detected by combining liquid phase capture and second-generation transcriptome sequencing, so that the sequencing cost required by the fusion gene detection is lower, the sensitivity is higher, meanwhile, the method disclosed by the invention also has the capability of new fusion discovery, and the result is more reliable.
Drawings
FIG. 1 is a schematic flow chart of the detection of clonal eosinophilia fusion genes based on the sequencing of a targeted capture transcriptome library.
FIG. 2 is a view showing the reading pattern of the fusion of the gene for clonal hypereosinophilia in the present invention.
FIG. 3 is a general technical roadmap for the detection method of the present invention.
Detailed Description
To further illustrate the technical means adopted by the present invention and the effects thereof, the present invention is further described below with reference to the embodiments and the accompanying drawings. It is to be understood that the specific embodiments described herein are merely illustrative of the invention and are not limiting of the invention.
The examples do not show the specific techniques or conditions, according to the technical or conditions described in the literature in the field, or according to the product specifications. The reagents or apparatus used are conventional products commercially available from normal sources, not indicated by the manufacturer.
Example 1
This example performed a fusion assay on bone marrow samples from patients with clonal eosinophilia.
(1) Nucleic acid extraction
The sample and EL buffer were added at a ratio of 1:5 and incubated on ice, vortexed briefly for 2 times during incubation to lyse red blood cells, followed by 400 ℃ at 4 ℃×gCentrifuging for 10min, and discarding the supernatant; adding EL buffer solution (2 times of sample volume) at a ratio of 1:2, mixing by brief vortex, and stirring at 400 deg.C×gCentrifuging for 10min, and discarding the supernatant;
adding a proper RLT buffer solution according to the volume of the sample to dissolve the white blood cells, uniformly mixing by vortex or blowing, transferring to a lysis column, centrifuging at the maximum rotation speed for 2 min, and collecting filtrate; adding 1 volume time of 70% ethanol into the filtrate, blowing, mixing, transferring to a filter column, 8000×gCentrifuging for 15s, and discarding the collection pipe; transfer the filter column to a fresh collection tube and add 350. mu.L RW1 buffer, 8000×gCentrifuging for 15s, and discarding the filtrate;
slightly and uniformly mixing 10 mu L of DNase I and 70 mu L of RDD buffer solution, adding the mixture into a filter column, and incubating for 15min at 30 ℃; 350. mu.L of RW1 buffer, 8000×gCentrifuging for 15s, and discarding the collection pipe; transfer the filter column to a fresh collection tube and add 500. mu.L of RPE buffer, 8000×gCentrifuging for 15s, and discarding the filtrate;
add 500. mu.L RPE buffer, 20000×gCentrifuging for 3 min, discarding the filtrate, transferring the filter column to a new collecting tube, centrifuging at full speed for 1min, and discarding the centrifuge tube; the filter column was transferred to a 1.5 mL centrifuge tube and 50. mu.L of nucleic-free H was added2O, standing at room temperature for 5min at 8000×gCentrifuging for 1min to obtain filtrate as the extracted RNA;
(2) mRNA enrichment
The RNA extracted above was quantified using a Qubit, 1000 ng of RNA was put into a 1.5 mL centrifuge tube, the volume was made up to 50. mu.L with ribozyme-free water, and the RNA was pipetted and mixed on ice for further use.
Preparing a mixed solution in advance: the mixture was prepared on ice according to table 3 below, vortexed, and centrifuged instantaneously.
Figure 470465DEST_PATH_IMAGE003
Aspirate 20. mu.L of Oligo dT Beads d (T) and mix well with vortex, equilibrate at room temperature for more than 30 min25And washing twice with 100 μ L of RNA 2 × Binding Buffer;
adding 50 mu L of 2 XRNA Binding Buffer into each reaction, and uniformly mixing by blowing for 10 times; transferring 50 mu L of magnetic bead solution into a 50 mu L of Total RNA reaction tube, and blowing, beating and uniformly mixing;
carrying out reaction in a PCR instrument (thermal cover is more than or equal to 75 ℃, incubation is carried out at 65 ℃ for 5min, Hold is carried out at 4 ℃, and the reaction system is 100 muL);
after the reaction is finished, uniformly blowing and stirring the product, and standing for 5min at room temperature; transferring the centrifuge tube to a magnetic rack until the liquid is completely clarified (about 2 min), removing the supernatant, and retaining the magnetic beads;
taking the centrifugal tube off the magnetic frame, washing twice by 200 mu L of Wash Buffer, adding 50 mu L of Tris Buffer into the reaction tube, and blowing and uniformly mixing; carrying out reaction in a PCR instrument (thermal cover is more than or equal to 90 ℃, incubation is carried out for 2 min at 80 ℃, Hold is carried out at 25 ℃, and the reaction system is 50 muL);
after the reaction is finished, taking down the product from the PCR instrument, adding 50 mu L of 2 xRNA Binding Buffer into a reaction tube, blowing and mixing uniformly, and incubating for 5min at room temperature;
transferring the centrifuge tube to a magnetic rack until the liquid is completely clarified (about 2 min), removing the supernatant, and retaining the magnetic beads; the reaction tube was washed once with 200. mu.L of Wash Buffer.
(3) mRNA Pre-library construction
Taking down the centrifugal tube from the magnetic frame, adding 11.5 mu L of the mixed solution prepared in advance into the reaction tube, and blowing, beating and uniformly mixing;
carrying out reaction in a PCR instrument (thermal cover is more than or equal to 105 ℃, incubation is carried out at 94 ℃ for 10min, Hold is carried out at 4 ℃, and the reaction system is 12 muL); when the temperature of the sample is reduced to 65 ℃, the sample is quickly taken out and placed on ice to stand for 1 min.
The centrifuge tube was transferred to a magnetic rack until the liquid was completely clear (about 2 min); carefully pipette 10. mu.L of the supernatant into a new 200. mu.L PCR tube, discard the beads, and place on ice;
preparing a chain of synthetic mixed solution on ice according to table 4, blowing, beating, mixing uniformly, and performing instantaneous centrifugation:
Figure 729408DEST_PATH_IMAGE004
carrying out reaction in a PCR instrument (the thermal cover is more than or equal to 80 ℃, the incubation is carried out for 10min at 25 ℃, the incubation is carried out for 15min at 42 ℃, the incubation is carried out for 15min at 70 ℃, the Hold is carried out at 4 ℃, and the reaction system is 20 muL);
preparing a two-chain synthesis mixed solution on ice according to the following table 5, blowing, beating and mixing uniformly, and performing instantaneous centrifugation:
Figure 687000DEST_PATH_IMAGE005
the reaction was carried out in a PCR instrument (hot lid. ltoreq.40 ℃, 16 ℃ incubation for 60 min, 4 ℃ Hold, reaction system: 80 μ L)
Adding an End Prep Reaction Buffer and an End Prep Enzyme Mix into ds cDNA to prepare a connection system with the total volume of 60 mu L, carrying out Reaction in a PCR instrument (a hot cover is more than or equal to 75 ℃, incubation is carried out at 20 ℃ for 30 min, incubation is carried out at 65 ℃ for 30 min, Hold is carried out at 4 ℃, the Reaction system is 60 mu L), and carrying out ice operation in the whole process;
adding the Ligation Master Mix, Ligation Enhancer, Adapter and nucleic-free H2O preparing a connecting system with the total volume of 93.5 mu L, performing connecting reaction in a PCR instrument (hot cover 105 ℃, incubation at 20 ℃ for 15min, Hold at 4 ℃), and performing ice operation in the whole process;
purifying the ligation product, adding a PCR Primer Mix and an Ultra II Q5 Master Mix into the purified adaptor ligation product to prepare a PCR reaction system with the total volume of 50 mu L, and performing library amplification reaction in a PCR instrument (hot cover 105 ℃, pre-denaturation at 98 ℃ for 30 s, denaturation at 98 ℃ for 10 s, annealing and extension at 65 ℃ for 75 s, amplification for 10 cycles, complete extension at 65 ℃ for 5min, and Hold at 4 ℃);
and purifying the PCR product to obtain a purified product, namely the pre-library.
Example 2 fusion Gene-related fragment Capture of interest
(1) Capturing target fragments
Putting the pre-library with the total amount of 2 mu g into a new 1.5 mL centrifuge tube, adding 5 mu L of Human Cot-1 DNA and 2 mu L of Universal bottles, covering a tube cover, pricking the tube cover with a disposable syringe, putting the tube cover into a vacuum concentrator, and drying at the constant temperature of 60 ℃ until no liquid exists;
adding a total volume of 17 μ L of Hybridization solution (including 2 × Hybridization Buffer, Hybridization Buffer Enhancer, probe composition and nucleic-Free Water, wherein the concentration of the probe composition in the reaction system is 400 amol/probe/rxn), mixing, standing at room temperature for 5min, transferring to a PCR tube, and running HYB program (hot lid 100 ℃, 95 ℃ for 30 s, 65 ℃ for 4 h, 65 ℃ Hold);
after the HYB program is operated, transferring the cleaned 17 mu L M-270 magnetic bead solution into a hybridization reaction tube, blowing and uniformly mixing, and incubating for 45 min at 65 ℃ in a PCR instrument;
after incubation at 65 ℃, adding 100 mu L of 1 × Wash Buffer1 preheated at 65 ℃ into a hybridization reaction tube, blowing and uniformly mixing, transferring the centrifugal tube to a magnetic frame until the liquid is completely clarified, sucking and removing the supernatant, and keeping magnetic beads;
taking down the centrifuge tube, adding 150 μ L of 1 × Stringent Wash Buffer preheated at 65 deg.C, blowing, mixing, incubating at 65 deg.C for 5min, transferring the centrifuge tube to magnetic frame until the liquid is completely clarified, removing supernatant, and retaining magnetic beads; repeating the steps once;
taking down the centrifuge tube, adding 150 mu L of room temperature 1 × Wash Buffer1, washing, removing supernatant and keeping magnetic beads; then adding 150 mu L of room temperature 1 XWash Buffer 2, washing, removing supernatant by suction, and keeping magnetic beads; 150 μ L of room temperature 1 × Wash Buffer3 was added, washed, the supernatant was aspirated off, the beads were retained, and 20 μ L of nucleic-free H was added2And O, blowing, beating and mixing uniformly for later use.
(2) Capture library amplification and sequencing
Adding 30 mu L of PCR Master Mix into the magnetic bead resuspension solution, blowing, uniformly mixing, and carrying out library amplification reaction in a PCR instrument (hot cover 105 ℃, pre-denaturation at 98 ℃ for 45 s, denaturation at 98 ℃ for 15s, annealing at 60 ℃ for 30 s, extension at 72 ℃ for 30 s, amplification for 7-9 cycles, complete extension at 72 ℃ for 1min, and Hold at 4 ℃);
purifying the PCR product to obtain a purified product, namely a probe capture library;
performing double-ended sequencing by adopting a well-known Illumina NGS sequencing technology, and analyzing and processing the obtained double-ended sequencing data by the following steps:
1) comparing the read sequences obtained by sequencing with a reference genome, and screening out the read sequences which can not be completely matched with a single gene as candidate fusion gene sequences;
2) and comparing the candidate fusion gene sequence with the reference genome annotation file, and predicting the fusion gene according to the overlapping condition of the reading sequence. Performing further correction analysis according to the minimum reading support criterion and by using a checking tool;
3) the prediction results were filtered to remove false positive fusions.
The final positive fusion gene determination conditions were: the sum of the numbers of the supported binding reading sequences and cross breakpoint reading sequences of the candidate fusion genes after the data processing is not less than 4.
Example 3
This example uses bone marrow samples from 6 clinically suspected eosinophilia patients.
The detection method comprises the steps as shown in fig. 3: firstly, extracting RNA in a sample, then carrying out mRNA enrichment, and then carrying out pre-library construction, wherein the pre-library construction comprises the following steps: performing RNA thermal interruption, performing reverse transcription on fragmented RNA to convert the fragmented RNA into cDNA, and performing terminal repair, A tail addition, linker addition and PCR amplification; then, the probe composition of the present invention is used for hybrid capture, which comprises: closing library DNA, washing with magnetic beads, hybridizing, eluting to obtain a capture library, amplifying, and purifying to obtain an on-machine detection;
the specific implementation steps are shown in example 1 and example 2.
The results are shown in Table 6, and in 6 clinically suspected eosinophilia patients, MYO18A-PDGFRB fusion was detected in one case, ETV6-ABL1 fusion was detected in two cases, CUX1-FGFR1 fusion was detected in one case, and related genes were not detected in the other two cases.
Meanwhile, in the present embodiment, the second-generation high-throughput transcriptome sequencing method is adopted for synchronous detection, and it is found that the detection results of 5 samples in total of TR02-TR06 are the same as that in the present embodiment, while no relevant fusion is detected in the TR01 sample by adopting the transcriptome sequencing method.
The above results show that the method for detecting the clonal eosinophilia-polycythemia fusion gene by targeted capturing RNA-seq has higher sensitivity, stronger detection capability on low-expression fusion transcripts and lower cost compared with the RNA-seq.
Figure 689591DEST_PATH_IMAGE006
In conclusion, the clonal eosinophilia-associated hypereosinophilia fusion gene detection probe composition, the kit constructed by applying the same and the detection method provided by the invention enable the sequencing cost required for detecting a sample to be detected to be lower, the sensitivity to be higher and the result to be accurate and reliable.
The applicant states that the present invention is illustrated in detail by the above examples, but the present invention is not limited to the above detailed methods, i.e. it is not meant that the present invention must rely on the above detailed methods for its implementation. It should be understood by those skilled in the art that any modification of the present invention, equivalent substitutions of the raw materials of the product of the present invention, addition of auxiliary components, selection of specific modes, etc., are within the scope and disclosure of the present invention.
SEQUENCE LISTING
<110> Mejie transformation medical research (Suzhou) Co., Ltd
<120> clonal eosinophilia hypereosinophilia fusion gene detection probe composition, kit and application thereof
<130> 20210527
<160> 310
<170> PatentIn version 3.3
<210> 1
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 1
aagagcaaaa agcgaaggcg caatctggac actgggagat tcggagcgca gggagtttga 60
gagaaacttt tattttgaag agaccaaggt tgaggggggg cttatttcct gacagctatt 120
<210> 2
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 2
tacttagagc aaatgattag ttttagaagg atggactata acattgaatc aattacaaaa 60
cgcggttttt gagcccatta ctgttggagc tacagggaga gaaacagagg aggagactgc 120
<210> 3
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 3
aagagatcat tggaggccgt gggcacgctc tttactccat gtgtgggaca ttcattgcgg 60
aataacatcg gaggagaagt ttcccagagc tatggggact tcccatccgg cgttcctggt 120
<210> 4
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 4
cttaggctgt cttctcacag ggctgagcct aatcctctgc cagctttcat taccctctat 60
ccttccaaat gaaaatgaaa aggttgtgca gctgaattca tccttttctc tgagatgctt 120
<210> 5
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 5
tggggagagt gaagtgagct ggcagtaccc catgtctgaa gaagagagct ccgatgtgga 60
aatcagaaat gaagaaaaca acagcggcct ttttgtgacg gtcttggaag tgagcagtgc 120
<210> 6
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 6
ctcggcggcc cacacagggt tgtacacttg ctattacaac cacactcaga cagaagagaa 60
tgagcttgaa ggcaggcaca tttacatcta tgtgccagac ccagatgtag cctttgtacc 120
<210> 7
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 7
tctaggaatg acggattatt tagtcatcgt ggaggatgat gattctgcca ttataccttg 60
tcgcacaact gatcccgaga ctcctgtaac cttacacaac agtgaggggg tggtacctgc 120
<210> 8
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 8
ctcctacgac agcagacagg gctttaatgg gaccttcact gtagggccct atatctgtga 60
ggccaccgtc aaaggaaaga agttccagac catcccattt aatgtttatg ctttaaaagc 120
<210> 9
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 9
aacatcagag ctggatctag aaatggaagc tcttaaaacc gtgtataagt caggggaaac 60
gattgtggtc acctgtgctg tttttaacaa tgaggtggtt gaccttcaat ggacttaccc 120
<210> 10
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 10
tggagaagtg aaaggcaaag gcatcacaat gctggaagaa atcaaagtcc catccatcaa 60
attggtgtac actttgacgg tccccgaggc cacggtgaaa gacagtggag attacgaatg 120
<210> 11
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 11
tgctgcccgc caggctacca gggaggtcaa agaaatgaag aaagtcacta tttctgtcca 60
tgagaaaggt ttcattgaaa tcaaacccac cttcagccag ttggaagctg tcaacctgca 120
<210> 12
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 12
tgaagtcaaa cattttgttg tagaggtgcg ggcctaccca cctcccagga tatcctggct 60
gaaaaacaat ctgactctga ttgaaaatct cactgagatc accactgatg tggaaaagat 120
<210> 13
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 13
tcaggaaata aggtatcgaa gcaaattaaa gctgatccgt gctaaggaag aagacagtgg 60
ccattatact attgtagctc aaaatgaaga tgctgtgaag agctatactt ttgaactgtt 120
<210> 14
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 14
aactcaagtt ccttcatcca ttctggactt ggtcgatgat caccatggct caactggggg 60
acagacggtg aggtgcacag ctgaaggcac gccgcttcct gatattgagt ggatgatatg 120
<210> 15
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 15
caaagatatt aagaaatgta ataatgaaac ttcctggact attttggcca acaatgtctc 60
aaacatcatc acggagatcc actcccgaga caggagtacc gtggagggcc gtgtgacttt 120
<210> 16
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 16
cgccaaagtg gaggagacca tcgccgtgcg atgcctggct aagaatctcc ttggagctga 60
gaaccgagag ctgaagctgg tggctcccac cctgcgttct gaactcacgg tggctgctgc 120
<210> 17
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 17
agtcctggtg ctgttggtga ttgtgatcat ctcacttatt gtcctggttg tcatttggaa 60
acagaaaccg aggtatgaaa ttcgctggag ggtcattgaa tcaatcagcc cagatggaca 120
<210> 18
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 18
tgaatatatt tatgtggacc cgatgcagct gccttatgac tcaagatggg agtttccaag 60
agatggacta gtgcttggtc gggtcttggg gtctggagcg tttgggaagg tggttgaagg 120
<210> 19
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 19
aacagcctat ggattaagcc ggtcccaacc tgtcatgaaa gttgcagtga agatgctaaa 60
acccacggcc agatccagtg aaaaacaagc tctcatgtct gaactgaaga taatgactca 120
<210> 20
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 20
cctggggcca catttgaaca ttgtaaactt gctgggagcc tgcaccaagt caggccccat 60
ttacatcatc acagagtatt gcttctatgg agatttggtc aactatttgc ataagaatag 120
<210> 21
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 21
ggatagcttc ctgagccacc acccagagaa gccaaagaaa gagctggata tctttggatt 60
gaaccctgct gatgaaagca cacggagcta tgttatttta tcttttgaaa acaatggtga 120
<210> 22
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 22
ctacatggac atgaagcagg ctgatactac acagtatgtc cccatgctag aaaggaaaga 60
ggtttctaaa tattccgaca tccagagatc actctatgat cgtccagcct catataagaa 120
<210> 23
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 23
gaaatctatg ttagactcag aagtcaaaaa cctcctttca gatgataact cagaaggcct 60
tactttattg gatttgttga gcttcaccta tcaagttgcc cgaggaatgg agtttttggc 120
<210> 24
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 24
ttcaaaaaat tgtgtccacc gtgatctggc tgctcgcaac gtcctcctgg cacaaggaaa 60
aattgtgaag atctgtgact ttggcctggc cagagacatc atgcatgatt cgaactatgt 120
<210> 25
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 25
gtcgaaaggc agtacctttc tgcccgtgaa gtggatggct cctgagagca tctttgacaa 60
cctctacacc acactgagtg atgtctggtc ttatggcatt ctgctctggg agatcttttc 120
<210> 26
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 26
ccttggtggc accccttacc ccggcatgat ggtggattct actttctaca ataagatcaa 60
gagtgggtac cggatggcca agcctgacca cgctaccagt gaagtctacg agatcatggt 120
<210> 27
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 27
gaaatgctgg aacagtgagc cggagaagag accctccttt taccacctga gtgagattgt 60
ggagaatctg ctgcctggac aatataaaaa gagttatgaa aaaattcacc tggacttcct 120
<210> 28
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 28
gaagagtgac catcctgctg tggcacgcat gcgtgtggac tcagacaatg catacattgg 60
tgtcacctac aaaaacgagg aagacaagct gaaggactgg gagggtggtc tggatgagca 120
<210> 29
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 29
gagactgagc gctgacagtg gctacatcat tcctctgcct gacattgacc ctgtccctga 60
ggaggaggac ctgggcaaga ggaacagaca cagctcgcag acctctgaag agagtgccat 120
<210> 30
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 30
tgagacgggt tccagcagtt ccaccttcat caagagagag gacgagacca ttgaagacat 60
cgacatgatg gatgacatcg gcatagactc ttcagacctg gtggaagaca gcttcctgta 120
<210> 31
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 31
actggcggat tcgaggggtt ccttccactt ctggggccac ctctggatcc cgttcagaaa 60
accactttat tgcaatgcag aggttgagag gaggacttgg ttgatgttta aagagaagtt 120
<210> 32
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 32
cccagccaag ggcctcgggg agcgttctaa atatgaatga atgggatatt ttgaaatgaa 60
ctttgtcagt gttgcctctt gcaatgcctc agtagcatct cagtggtgtg tgaagtttgg 120
<210> 33
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 33
agatagatgg ataagggaat aataggccac agaaggtgaa ctttgtgctt caaggacatt 60
ggtgagagtc caacagacac aatttatact gcgacagaac ttcagcattg taattatgta 120
<210> 34
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 34
aataactcta accaaggctg tgtttagatt gtattaacta tcttctttgg acttctgaag 60
agaccactca atccatccat gtacttccct cttgaaacct gatgtcagct gctgttgaac 120
<210> 35
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 35
tttttaaaga agtgcatgaa aaaccatttt tgaaccttaa aaggtactgg tactatagca 60
ttttgctatc ttttttagtg ttaaagagat aaagaataat aattaaccaa ccttgtttaa 120
<210> 36
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 36
tagatttggg tcatttagaa gcctgacaac tcattttcat attgtaatct atgtttataa 60
tactactact gttatcagta atgctaaatg tgtaataatg taacatgatt tccctccaga 120
<210> 37
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 37
gaaagcacaa tttaaaacaa tccttactaa gtaggtgatg agtttgacag tttttgacat 60
ttatattaaa taacatgttt ctctataaag tatggtaata gctttagtga attaaattta 120
<210> 38
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 38
gttgagcata gagaacaaag taaaagtagt gttgtccagg aagtcagaat ttttaactgt 60
actgaatagg ttccccaatc catcgtatta aaaaacaatt aactgccctc tgaaataatg 120
<210> 39
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 39
ggattagaaa caaacaaaac tcttaagtcc taaaagttct caatgtagag gcataaacct 60
gtgctgaaca taacttctca tgtatattac ccaatggaaa atataatgat cagcaaaaag 120
<210> 40
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 40
actggatttg cagaagtttt tttttttttt ttcttcatgc ctgatgaaag ctttggcgac 60
cccaatatat gtattttttg aatctatgaa cctgaaaagg gtcagaagga tgcccagaca 120
<210> 41
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 41
tcagcctcct tctttcaccc cttaccccaa agagaaagag tttgaaactc gagaccataa 60
agatattctt tagtggaggc tggatgtgca ttagcctgga tcctcagttc tcaaatgtgt 120
<210> 42
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 42
gtggcagcca ggatgactag atcctgggtt tccatccttg agattctgaa gtatgaagtc 60
tgagggaaac cagagtctgt atttttctaa actccctggc tgttctgatc ggccagtttt 120
<210> 43
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 43
cggaaacact gacttaggtt tcaggaagtt gccatgggaa acaaataatt tgaactttgg 60
aacagggttg gcattcaacc acgcaggaag cctactattt aaatccttgg cttcaggtta 120
<210> 44
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 44
gtgacattta atgccatcta gctagcaatt gcgaccttaa tttaactttc cagtcttagc 60
tgaggctgag aaagctaaag tttggttttg acaggttttc caaaagtaaa gatgctactt 120
<210> 45
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 45
cccactgtat gggggagatt gaactttccc cgtctcccgt cttctgcctc ccactccata 60
ccccgccaag gaaaggcatg tacaaaaatt atgcaattca gtgttccaag tctctgtgta 120
<210> 46
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 46
accagctcag tgttttggtg gaaaaaacat tttaagtttt actgataatt tgaggttaga 60
tgggaggatg aattgtcaca tctatccaca ctgtcaaaca ggttggtgtg ggttcattgg 120
<210> 47
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 47
cattctttgc aatactgctt aattgctgat accatatgaa tgaaacatgg gctgtgatta 60
ctgcaatcac tgtgctatcg gcagatgatg ctttggaaga tgcagaagca ataataaagt 120
<210> 48
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 48
acttgactac ctactggtgt aatctcaatg caagccccaa ctttcttatc caactttttc 60
atagtaagtg cgaagactga gccagattgg ccaattaaaa acgaaaacct gactaggttc 120
<210> 49
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 49
tgtagagcca attagacttg aaatacgttt gtgtttctag aatcacagct caagcattct 60
gtttatcgct cactctccct tgtacagcct tattttgttg gtgctttgca ttttgatatt 120
<210> 50
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 50
gctgtgagcc ttgcatgaca tcatgaggcc ggatgaaact tctcagtcca gcagtttcca 60
gtcctaacaa atgctcccac ctgaatttgt atatgactgc atttgtgtgt gtgtgtgtgt 120
<210> 51
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 51
tttcagcaaa ttccagattt gtttcctttt ggcctcctgc aaagtctcca gaagaaaatt 60
tgccaatctt tcctactttc tatttttatg atgacaatca aagccggcct gagaaacact 120
<210> 52
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 52
atttgtgact ttttaaacga ttagtgatgt ccttaaaatg tggtctgcca atctgtacaa 60
aatggtccta tttttgtgaa gagggacata agataaaatg atgttataca tcaatatgta 120
<210> 53
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 53
tatatgtatt tctatataga cttggagaat actgccaaaa catttatgac aagctgtatc 60
actgccttcg tttatatttt tttaactgtg ataatcccca caggcacatt aactgttgca 120
<210> 54
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 54
cttttgaatg tccaaaattt atattttaga aataataaaa agaaagatac ttacatgttc 60
ccaaaacaat ggtgtggtga atgtgtgaga aaaactaact tgatagggtc taccaataca 120
<210> 55
<211> 94
<212> DNA
<213> Artificial Synthesis
<400> 55
aaatgtatta cgaatgcccc tgttcatgtt tttgttttaa aacgtgtaaa tgaagatctt 60
tatatttcaa taaatgatat ataatttaaa gtta 94
<210> 56
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 56
agatgcaggg gcgcaaacgc caaaggagac caggctgtag gaagagaagg gcagagcgcc 60
ggacagctcg gcccgctccc cgtcctttgg ggccgcggct ggggaactac aaggcccagc 120
<210> 57
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 57
gcaggcagct gcagggggcg gaggcggagg agggaccagc gcgggtggga gtgagagagc 60
gagccctcgc gccccgccgg cgcatagcgc tcggagcgct cttgcggcca caggcgcggc 120
<210> 58
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 58
gcgtcctcgg cggcgggcgg cagctagcgg gagccgggac gccggtgcag ccgcagcgcg 60
cggaggaacc cgggtgtgcc gggagctggg cggccacgtc cggacgggac cgagacccct 120
<210> 59
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 59
ctcgtagcgc attgcggcga cctcgccttc cccggccgcg agcgcgccgc tgcttgaaaa 60
gccgcggaac ccaaggactt ttctccggtc cgagctcggg gcgccccgca gggcgcacgg 120
<210> 60
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 60
ggtacccgtg ctgcagtcgg gcacgccgcg gcgccggggc ctccgcaggg cgatggagcc 60
cggtctgcaa ggaaagtgag gcgccgccgc tgcgttctgg aggagggggg cacaaggtct 120
<210> 61
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 61
ctggagaccc cgggtggcgg acgggagccc tccccccgcc ccgcctccgg ggcaccagct 60
ccggctccat tgttcccgcc cgggctggag gcgccgagca ccgagcgccg ccgggagtcg 120
<210> 62
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 62
cgagcgccgg ccgcggagct cttgcgaccc cgccaggacc cgaacagagc ccgggggcgg 60
cgggccggag ccggggacgc gggcacacgc ccgctcgcac aagccacggc ggactctccc 120
<210> 63
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 63
ccgaggcgga acctccacgc cgagcgaggg tcagtttgaa aaggaggatc gagctcactg 60
tggagtatcc atggagatgt ggagccttgt caccaacctc taactgcaga actgggatgt 120
<210> 64
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 64
gtggagctgg aagtgcctcc tcttctgggc tgtgctggtc acagccacac tctgcaccgc 60
taggccgtcc ccgaccttgc ctgaacaagc ccagccctgg ggagcccctg tggaagtgga 120
<210> 65
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 65
gagtccttcc tggtccaccc cggtgacctg ctgcagcttc gctgtcggct gcgggacgat 60
gtgcagagca tcaactggct gcgggacggg gtgcagctgg cggaaagcaa ccgcacccgc 120
<210> 66
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 66
gcatcacagg ggaggaggtg gaggtgcagg actccgtgcc cgcagactcc ggcctctatg 60
cttgcgtaac cagcagcccc tcgggcagtg acaccaccta cttctccgtc aatgtttcag 120
<210> 67
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 67
agatgctctc ccctcctcgg aggatgatga tgatgatgat gactcctctt cagaggagaa 60
agaaacagat aacaccaaac caaaccgtat gcccgtagct ccatattgga catccccaga 120
<210> 68
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 68
gaaaagatgg aaaagaaatt gcatgcagtg ccggctgcca agacagtgaa gttcaaatgc 60
ccttccagtg ggaccccaaa ccccacactg cgctggttga aaaatggcaa agaattcaaa 120
<210> 69
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 69
aacctgacca cagaattgga ggctacaagg tccgttatgc cacctggagc atcataatgg 60
actctgtggt gccctctgac aagggcaact acacctgcat tgtggagaat gagtacggca 120
<210> 70
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 70
cagcatcaac cacacatacc agctggatgt cgtggagcgg tcccctcacc ggcccatcct 60
gcaagcaggg ttgcccgcca acaaaacagt ggccctgggt agcaacgtgg agttcatgtg 120
<210> 71
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 71
tgtaaggtgt acagtgaccc gcagccgcac atccagtggc taaagcacat cgaggtgaat 60
gggagcaaga ttggcccaga caacctgcct tatgtccaga tcttgaagac tgctggagtt 120
<210> 72
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 72
ttaataccac cgacaaagag atggaggtgc ttcacttaag aaatgtctcc tttgaggacg 60
caggggagta tacgtgcttg gcgggtaact ctatcggact ctcccatcac tctgcatggt 120
<210> 73
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 73
gttgaccgtt ctggaagccc tggaagagag gccggcagtg atgacctcgc ccctgtacct 60
ggagatcatc atctattgca caggggcctt cctcatctcc tgcatggtgg ggtcggtcat 120
<210> 74
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 74
atcgtctaca agatgaagag tggtaccaag aagagtgact tccacagcca gatggctgtg 60
cacaagctgg ccaagagcat ccctctgcgc agacaggtaa cagtgtctgc tgactccagt 120
<210> 75
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 75
gtgcatccat gaactctggg gttcttctgg ttcggccatc acggctctcc tccagtggga 60
ctcccatgct agcaggggtc tctgagtatg agcttcccga agaccctcgc tgggagctgc 120
<210> 76
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 76
gcctcgggac agactggtct taggcaaacc cctgggagag ggctgctttg ggcaggtggt 60
gttggcagag gctatcgggc tggacaagga caaacccaac cgtgtgacca aagtggctgt 120
<210> 77
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 77
gtgaagatgt tgaagtcgga cgcaacagag aaagacttgt cagacctgat ctcagaaatg 60
gagatgatga agatgatcgg gaagcataag aatatcatca acctgctggg ggcctgcacg 120
<210> 78
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 78
cgcaggatgg tcccttgtat gtcatcgtgg agtatgcctc caagggcaac ctgcgggagt 60
acctgcaggc ccggaggccc ccagggctgg aatactgcta caaccccagc cacaacccag 120
<210> 79
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 79
agaggagcag ctctcctcca aggacctggt gtcctgcgcc taccaggtgg cccgaggcat 60
ggagtatctg gcctccaaga agtgcataca ccgagacctg gcagccagga atgtcctggt 120
<210> 80
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 80
gtgacagagg acaatgtgat gaagatagca gactttggcc tcgcacggga cattcaccac 60
atcgactact ataaaaagac aaccaacggc cgactgcctg tgaagtggat ggcacccgag 120
<210> 81
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 81
aggcattatt tgaccggatc tacacccacc agagtgatgt gtggtctttc ggggtgctcc 60
tgtgggagat cttcactctg ggcggctccc cataccccgg tgtgcctgtg gaggaacttt 120
<210> 82
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 82
tttcaagctg ctgaaggagg gtcaccgcat ggacaagccc agtaactgca ccaacgagct 60
gtacatgatg atgcgggact gctggcatgc agtgccctca cagagaccca ccttcaagca 120
<210> 83
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 83
cagctggtgg aagacctgga ccgcatcgtg gccttgacct ccaaccagga gtacctggac 60
ctgtccatgc ccctggacca gtactccccc agctttcccg acacccggag ctctacgtgc 120
<210> 84
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 84
gctcctcagg ggaggattcc gtcttctctc atgagccgct gcccgaggag ccctgcctgc 60
cccgacaccc agcccagctt gccaatggcg gactcaaacg ccgctgactg ccacccacac 120
<210> 85
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 85
acgccctccc cagactccac cgtcagctgt aaccctcacc cacagcccct gctgggccca 60
ccacctgtcc gtccctgtcc cctttcctgc tggcaggagc cggctgccta ccaggggcct 120
<210> 86
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 86
cttcctgtgt ggcctgcctt caccccactc agctcacctc tccctccacc tcctctccac 60
ctgctggtga gaggtgcaaa gaggcagatc tttgctgcca gccacttcat cccctcccag 120
<210> 87
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 87
agatgttgga ccaacacccc tccctgccac caggcactgc ctggagggca gggagtggga 60
gccaatgaac aggcatgcaa gtgagagctt cctgagcttt ctcctgtcgg tttggtctgt 120
<210> 88
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 88
gttttgcctt cacccataag cccctcgcac tctggtggca ggtgccttgt cctcagggct 60
acagcagtag ggaggtcagt gcttcgtgcc tcgattgaag gtgacctctg ccccagatag 120
<210> 89
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 89
aggtggtgcc agtggcttat taattccgat actagtttgc tttgctgacc aaatgcctgg 60
taccagagga tggtgaggcg aaggccaggt tgggggcagt gttgtggccc tggggcccag 120
<210> 90
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 90
agccccaaac tgggggctct gtatatagct atgaagaaaa cacaaagtgt ataaatctga 60
gtatatattt acatgtcttt ttaaaagggt cgttaccaga gatttaccca tcgggtaaga 120
<210> 91
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 91
gatgctcctg gtggctggga ggcatcagtt gctatatatt aaaaacaaaa aagaaaaaaa 60
aggaaaatgt ttttaaaaag gtcatatatt ttttgctact tttgctgttt tattttttta 120
<210> 92
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 92
taaattatgt tctaaaccta ttttcagttt aggtccctca ataaaaattg ctgctgcttc 60
atttatctat gggctgtatg aaaagggtgg gaatgtccac tggaaagaag ggacacccac 120
<210> 93
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 93
acgggccctg gggctaggtc tgtcccgagg gcaccgcatg ctcccggcgc aggttccttg 60
taacctcttc ttcctaggtc ctgcacccag acctcacgac gcacctcctg cctctccgct 120
<210> 94
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 94
ctgcttttgg aaagtcagaa aaagaagatg tctgcttcga gggcaggaac cccatccatg 60
cagtagaggc gctgggcaga gagtcaaggc ccagcagcca tcgaccatgg atggtttcct 120
<210> 95
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 95
ctccaaggaa accggtgggg ttgggctggg gagggggcac ctacctagga atagccacgg 60
ggtagagcta cagtgattaa gaggaaagca agggcgcggt tgctcacgcc tgtaatccca 120
<210> 96
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 96
cagcactttg ggacaccgag gtgggcagat cacttcaggt caggagtttg agaccagcct 60
ggccaactta gtgaaacccc atctctacta aaaatgcaaa aattatccag gcatggtggc 120
<210> 97
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 97
gcacacgcct gtaatcccag ctccacagga ggctgaggca gaatcccttg aagctgggag 60
gcggaggttg cagtgagccg agattgcgcc attgcactcc agcctgggca acagagaaaa 120
<210> 98
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 98
aacaaaaagg aaaacaaatg atgaaggtct gcagaaactg aaacccagac atgtgtctgc 60
cccctctatg tgggcatggt tttgccagtg cttctaagtg caggagaaca tgtcacctga 120
<210> 99
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 99
gaggctagtt ttgcattcag gtccctggct tcgtttcttg ttggtatgcc tccccagatc 60
gtccttcctg tatccatgtg accagactgt atttgttggg actgtcgcag atcttggctt 120
<210> 100
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 100
ttcttacagt tcttcctgtc caaactccat cctgtccctc aggaacgggg ggaaaattct 60
ccgaatgttt ttggtttttt ggctgcttgg aatttacttc tgccacctgc tggtcatcac 120
<210> 101
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 101
actgtcctca ctaagtggat tctggctccc ccgtacctca tggctcaaac taccactcct 60
cagtcgctat attaaagctt atattttgct ggattactgc taaatacaaa agaaagttca 120
<210> 102
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 102
caatatgttt tcatttctgt agggaaaatg ggattgctgc tttaaatttc tgagctaggg 60
attttttggc agctgcagtg ttggcgacta ttgtaaaatt ctctttgttt ctctctgtaa 120
<210> 103
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 103
aaatagcacc tgctaacatt acaatttgta tttatgttta aagaaggcat catttggtga 60
acagaactag gaaatgaatt tttagctctt aaaagcattt gctttgagac cgcacaggag 120
<210> 104
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 104
agtgtctttc cttgtaaaac agtgatgata atttctgcct tggccctacc ttgaagcaat 60
gttgtgtgaa gggatgaaga atctaaaagt cttcataagt ccttgggaga ggtgctagaa 120
<210> 105
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 105
aaaaatataa ggcactatca taattacagt gatgtccttg ctgttactac tcaaatcacc 60
cacaaatttc cccaaagact gcgctagctg tcaaataaaa gacagtgaaa ttgacctgaa 120
<210> 106
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 106
ctcctgaggc tgccagcagc cagcagtgac tgcccgccct atctgggacc caggatcgct 60
ctgtgagcaa cttggagcca gagaggagat caacaaggag gaggagagag ccggcccctc 120
<210> 107
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 107
cagccctgct gcccagcagc agcctgtgct cgccctgccc aacgcagaca gccagaccca 60
gggcggcccc tctggcggct ctgctcctcc cgaaggatgc ttggggagtg aggcgaagct 120
<210> 108
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 108
tgggccgctc ctctccccta cagcagcccc cttcctccat ccctctgttc tcctgagcct 60
tcaggagcct gcaccagtcc tgcctgtcct tctactcagc tgttacccac tctgggacca 120
<210> 109
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 109
agcagtcttt ctgataactg ggagagggca gtaaggagga cttcctggag ggggtgactg 60
tccagagcct ggaactgtgc ccacaccaga agccatcagc agcaaggaca ccatgcggct 120
<210> 110
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 110
ttccgggtgc gatgccagct ctggccctca aaggcgagct gctgttgctg tctctcctgt 60
tacttctgga accacagatc tctcagggcc tggtcgtcac acccccgggg ccagagcttg 120
<210> 111
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 111
gtcctcaatg tctccagcac cttcgttctg acctgctcgg gttcagctcc ggtggtgtgg 60
gaacggatgt cccaggagcc cccacaggaa atggccaagg cccaggatgg caccttctcc 120
<210> 112
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 112
cagcgtgctc acactgacca acctcactgg gctagacacg ggagaatact tttgcaccca 60
caatgactcc cgtggactgg agaccgatga gcggaaacgg ctctacatct ttgtgccaga 120
<210> 113
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 113
atcccaccgt gggcttcctc cctaatgatg ccgaggaact attcatcttt ctcacggaaa 60
taactgagat caccattcca tgccgagtaa cagacccaca gctggtggtg acactgcacg 120
<210> 114
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 114
gagaagaaag gggacgttgc actgcctgtc ccctatgatc accaacgtgg cttttctggt 60
atctttgagg acagaagcta catctgcaaa accaccattg gggacaggga ggtggattct 120
<210> 115
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 115
tgatgcctac tatgtctaca gactccaggt gtcatccatc aacgtctctg tgaacgcagt 60
gcagactgtg gtccgccagg gtgagaacat caccctcatg tgcattgtga tcgggaatga 120
<210> 116
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 116
aggtggtcaa cttcgagtgg acataccccc gcaaagaaag tgggcggctg gtggagccgg 60
tgactgactt cctcttggat atgccttacc acatccgctc catcctgcac atccccagtg 120
<210> 117
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 117
gccgagttag aagactcggg gacctacacc tgcaatgtga cggagagtgt gaatgaccat 60
caggatgaaa aggccatcaa catcaccgtg gttgagagcg gctacgtgcg gctcctggga 120
<210> 118
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 118
agaggtgggc acactacaat ttgctgagct gcatcggagc cggacactgc aggtagtgtt 60
cgaggcctac ccaccgccca ctgtcctgtg gttcaaagac aaccgcaccc tgggcgactc 120
<210> 119
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 119
ccagcgctgg cgaaatcgcc ctgtccacgc gcaacgtgtc ggagacccgg tatgtgtcag 60
agctgacact ggttcgcgtg aaggtggcag aggctggcca ctacaccatg cgggccttcc 120
<210> 120
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 120
catgaggatg ctgaggtcca gctctccttc cagctacaga tcaatgtccc tgtccgagtg 60
ctggagctaa gtgagagcca ccctgacagt ggggaacaga cagtccgctg tcgtggccgg 120
<210> 121
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 121
gggcatgccc cagccgaaca tcatctggtc tgcctgcaga gacctcaaaa ggtgtccacg 60
tgagctgccg cccacgctgc tggggaacag ttccgaagag gagagccagc tggagactaa 120
<210> 122
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 122
acgtgacgta ctgggaggag gagcaggagt ttgaggtggt gagcacactg cgtctgcagc 60
acgtggatcg gccactgtcg gtgcgctgca cgctgcgcaa cgctgtgggc caggacacgc 120
<210> 123
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 123
caggaggtca tcgtggtgcc acactccttg ccctttaagg tggtggtgat ctcagccatc 60
ctggccctgg tggtgctcac catcatctcc cttatcatcc tcatcatgct ttggcagaag 120
<210> 124
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 124
gaagccacgt tacgagatcc gatggaaggt gattgagtct gtgagctctg acggccatga 60
gtacatctac gtggacccca tgcagctgcc ctatgactcc acgtgggagc tgccgcggga 120
<210> 125
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 125
accagcttgt gctgggacgc accctcggct ctggggcctt tgggcaggtg gtggaggcca 60
cggctcatgg cctgagccat tctcaggcca cgatgaaagt ggccgtcaag atgcttaaat 120
<210> 126
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 126
tccacagccc gcagcagtga gaagcaagcc cttatgtcgg agctgaagat catgagtcac 60
cttgggcccc acctgaacgt ggtcaacctg ttgggggcct gcaccaaagg aggacccatc 120
<210> 127
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 127
ctatatcatc actgagtact gccgctacgg agacctggtg gactacctgc accgcaacaa 60
acacaccttc ctgcagcacc actccgacaa gcgccgcccg cccagcgcgg agctctacag 120
<210> 128
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 128
gcaatgctct gcccgttggg ctccccctgc ccagccatgt gtccttgacc ggggagagcg 60
acggtggcta catggacatg agcaaggacg agtcggtgga ctatgtgccc atgctggaca 120
<210> 129
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 129
atgaaaggag acgtcaaata tgcagacatc gagtcctcca actacatggc cccttacgat 60
aactacgttc cctctgcccc tgagaggacc tgccgagcaa ctttgatcaa cgagtctcca 120
<210> 130
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 130
agtgctaagc tacatggacc tcgtgggctt cagctaccag gtggccaatg gcatggagtt 60
tctggcctcc aagaactgcg tccacagaga cctggcggct aggaacgtgc tcatctgtga 120
<210> 131
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 131
aaggcaagct ggtcaagatc tgtgactttg gcctggctcg agacatcatg cgggactcga 60
attacatctc caaaggcagc acctttttgc ctttaaagtg gatggctccg gagagcatct 120
<210> 132
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 132
ttcaacagcc tctacaccac cctgagcgac gtgtggtcct tcgggatcct gctctgggag 60
atcttcacct tgggtggcac cccttaccca gagctgccca tgaacgagca gttctacaat 120
<210> 133
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 133
tgccatcaaa cggggttacc gcatggccca gcctgcccat gcctccgacg agatctatga 60
gatcatgcag aagtgctggg aagagaagtt tgagattcgg ccccccttct cccagctggt 120
<210> 134
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 134
tgctgcttct cgagagactg ttgggcgaag gttacaaaaa gaagtaccag caggtggatg 60
aggagtttct gaggagtgac cacccagcca tccttcggtc ccaggcccgc ttgcctgggt 120
<210> 135
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 135
ttccatggcc tccgatctcc cctggacacc agctccgtcc tctatactgc cgtgcagccc 60
aatgagggtg acaacgacta tatcatcccc ctgcctgacc ccaaacccga ggttgctgac 120
<210> 136
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 136
cgagggccca ctggagggtt cccccagcct agccagctcc accctgaatg aagtcaacac 60
ctcctcaacc atctcctgtg acagccccct ggagccccag gacgaaccag agccagagcc 120
<210> 137
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 137
cccagcttga gctccaggtg gagccggagc cagagctgga acagttgccg gattcggggt 60
gccctgcgcc tcgggcggaa gcagaggata gcttcctgta gggggctggc ccctaccctg 120
<210> 138
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 138
gccctgcctg aagctccccc cctgccagca cccagcatct cctggcctgg cctgaccggg 60
cttcctgtca gccaggctgc ccttatcagc tgtccccttc tggaagcttt ctgctcctga 120
<210> 139
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 139
acgtgttgtg ccccaaaccc tggggctggc ttaggaggca agaaaactgc aggggccgtg 60
accagccctc tgcctccagg gaggccaact gactctgagc cagggttccc ccagggaact 120
<210> 140
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 140
tcagttttcc catatgtaag atgggaaagt taggcttgat gacccagaat ctaggattct 60
ctccctggct gacaggtggg gagaccgaat ccctccctgg gaagattctt ggagttactg 120
<210> 141
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 141
gaggtggtaa attaactttt ttctgttcag ccagctaccc ctcaaggaat catagctctc 60
tcctcgcact tttatccacc caggagctag ggaagagacc ctagcctccc tggctgctgg 120
<210> 142
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 142
gctgagctag ggcctagcct tgagcagtgt tgcctcatcc agaagaaagc cagtctcctc 60
cctatgatgc cagtccctgc gttccctggc ccgagctggt ctggggccat taggcagcct 120
<210> 143
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 143
taattaatgc tggaggctga gccaagtaca ggacaccccc agcctgcagc ccttgcccag 60
ggcacttgga gcacacgcag ccatagcaag tgcctgtgtc cctgtccttc aggcccatca 120
<210> 144
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 144
agtcctgggg ctttttcttt atcaccctca gtcttaatcc atccaccaga gtctagaagg 60
ccagacgggc cccgcatctg tgatgagaat gtaaatgtgc cagtgtggag tggccacgtg 120
<210> 145
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 145
gtgtgtgcca gtatatggcc ctggctctgc attggacctg ctatgaggct ttggaggaat 60
ccctcaccct ctctgggcct cagtttcccc ttcaaaaaat gaataagtcg gacttattaa 120
<210> 146
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 146
actctgagtg ccttgccagc actaacattc tagagtattc caggtggttg cacatttgtc 60
cagatgaagc aaggccatat accctaaact tccatcctgg gggtcagctg ggctcctggg 120
<210> 147
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 147
gagattccag atcacacatc acactctggg gactcaggaa ccatgcccct tccccaggcc 60
cccagcaagt ctcaagaaca cagctgcaca ggccttgact tagagtgaca gccggtgtcc 120
<210> 148
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 148
ctggaaagcc cccagcagct gccccaggga catgggaaga ccacgggacc tctttcacta 60
cccacgatga cctccggggg tatcctgggc aaaagggaca aagagggcaa atgagatcac 120
<210> 149
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 149
cctcctgcag cccaccactc cagcacctgt gccgaggtct gcgtcgaaga cagaatggac 60
agtgaggaca gttatgtctt gtaaaagaca agaagcttca gatgggtacc ccaagaagga 120
<210> 150
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 150
atgtgagagg tgggcgcttt ggaggtttgc ccctcaccca ccagctgccc catccctgag 60
gcagcgctcc atgggggtat ggttttgtca ctgcccagac ctagcagtga catctcattg 120
<210> 151
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 151
gtccccagcc cagtgggcat tggaggtgcc aggggagtca gggttgtagc caagacgccc 60
ccgcacgggg agggttggga agggggtgca ggaagctcaa cccctctggg caccaaccct 120
<210> 152
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 152
tgcattgcag gttggcacct tacttccctg ggatccccag agttggtcca aggagggaga 60
gtgggttctc aatacggtac caaagatata atcacctagg tttacaaata tttttaggac 120
<210> 153
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 153
ctcacgttaa ctcacattta tacagcagaa atgctatttt gtatgctgtt aagtttttct 60
atctgtgtac ttttttttaa gggaaagatt ttaatattaa acctggtgct tctcactcac 120
<210> 154
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 154
gatgaacaat acagaaactt cctcagaagt gtatccttgc tgaagaattt acctgaagat 60
aaattaacca agatcattga ctgcttggaa gtggaatact atgacaaagg agattacatc 120
<210> 155
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 155
cattagagag ggcgaggaag gaagtacctt tttcattttg gcaaaaggaa aggtaaaagt 60
aacacagagc acagaaggcc atgatcaacc acagctgata aaaacactgc agaaaggaga 120
<210> 156
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 156
aatactttgg agaaaaagct cttatcagtg atgatgtcag gtcagctaac attattgctg 60
aagaaaatga tgttgcatgc ctggttatag atcgagaaac attcaaccaa actgtcggta 120
<210> 157
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 157
agaagcggga gctggagggc aagctcgcca ccctcagcga ccaggtgaac cggcgggact 60
ttgagtcaga gaagcggctg cggaaggacc tgaagcgcac caaggccctg ctggcagatg 120
<210> 158
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 158
cccagctcat gctggaccac ctgaagaaca gtgctcccag caagcgagag attgcccagc 60
tcaagaacca gctggaggag tcagagttca cctgtgcggc agccgtgaaa gcacggaaag 120
<210> 159
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 159
caatggaggt ggagatcgaa gacctgcacc tgcagattga tgacatcgcc aaagccaaga 60
cagcgctgga ggagcagctg agccgccttc agcgtgagaa gaatgagatc cagaaccggc 120
<210> 160
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 160
tggaggaaga tcaggaagac atgaacgaat tgatgaagaa gcacaaggct gccgtggctc 60
aggcttcccg ggacctggct cagataaatg atctccaagc tcagctagaa gaagccaaca 120
<210> 161
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 161
aagagaagca ggagctgcag gagaagctac aagccctcca gagccaggtg gagttcctgg 60
agcagtccat ggtggacaag tccctggtga gcaggcagga agctaagata cgggagctgg 120
<210> 162
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 162
agacacgcct ggagtttgaa aggacgcaag tgaaacggct ggagagcctg gctagccgtc 60
tcaaggaaaa catggagaag ctgactgagg agcgggatca gcgcattgca gccgagaacc 120
<210> 163
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 163
taaagagttc cagccccacc agctactgga agtcccttgc ccctgatcgg tcagatgatg 60
agcacgaccc tctcgacaac acctccagac cgcgatactc ccacagttat ctgagtgaca 120
<210> 164
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 164
gcgacacaga ggccaagctg acggagacta acgcatagcc caggggagtg gttggcagcc 60
ctctcacccc agggcctgtg gctgcctggg cacctctccc aggaagtggt ggggcaccgg 120
<210> 165
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 165
aagaagacgc cagtttgatg aagaatcact ggaaagcttt agcagtatgc ctgatccagt 60
agatccaaca acagtgacta aaacattcaa gacaagaaaa gcgtctgcac aggccagcct 120
<210> 166
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 166
tggcatctaa agataaaact cccaagtcaa aaagtaagaa gaggaattct actcagctga 60
aaagcagagt taaaaacatc aggtatgaaa gtgccagtat gtctagcaca tgtgaacctt 120
<210> 167
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 167
tgcaaaagta ggaacagaca ttcagcccag actgaagagc ctgttcaagc aaaagtattc 60
agcagaaaga atcatgagca actggaaaaa ataataaaat gtaataggtc tacagaaata 120
<210> 168
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 168
atcttcagaa actgggagtg atttttccat gtttgaagct ttgcgagata ctatttattc 60
tgaagtagct acattaattt ctcaaaatga atctcgtcca cattttctta ttgaactctt 120
<210> 169
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 169
tccatgagct gcagctacta aacacagact acttgagaca gagggcttta tatgcattgc 60
aggacatagt atccagacat atttctgaga gccatgaaaa aggagaaaat gtaaagtcag 120
<210> 170
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 170
gtaaactctg gtacttggat agcatcaaac tcagaactta ctcctagtga gagccttgct 60
actactgatg atgaaacttt tgagaagaac tttgaaagag aaacccataa aataagtgag 120
<210> 171
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 171
gcaaaatgat gctgataatg ctagtgtcct gtctgtatca tcaaattttg agccttttgc 60
aacagatgat ctaggtaaca ccgtgattca cttagatcaa gcattagcca gaatgagaga 120
<210> 172
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 172
taaatagtgc tgcccataag gagtcacctc ctactgttga ttcaactcaa cagcctaacc 60
ctttgccgtt acgtttacct gaaatggaac ccttagtgcc tagagtcaaa gaagttaaat 120
<210> 173
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 173
tctgctcagg aaactcctga aagctctctg gctggaagtc ctgatactga atctccagtg 60
ttagtgaatg actatgaagc agaatctggt aatataagtc aaaagtctga tgaagaagat 120
<210> 174
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 174
ttttgtaaaa gttgaagatt taccactgaa actgacaata tattcagagg cagatctaag 60
aaagaaaatg gtagaagaag aacagaaaaa ccatttatct ggtgaaatat gtgaaatgca 120
<210> 175
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 175
atgcagctga tctggtggta caaggcagag ggaaatttga ggagctaatg gtgtgttctc 60
atgaaattgc tgctagcaca gcccagcttg tggctgcatc caaggtgaaa gctgataagg 120
<210> 176
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 176
ggacagcccc aacctagccc agctgcagca ggcctctcgg ggagtgaacc aggccactgc 60
cggcgttgtg gcctcaacca tttccggcaa atcacagatc gaagagacag acaacatgga 120
<210> 177
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 177
gacttctcaa gcatgacgct gacacagatc aaacgccaag agatggattc tcaggttagg 60
gtgctagagc tagaaaatga attgcagaag gagcgtcaaa aactgggaga gcttcggaaa 120
<210> 178
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 178
aagcgagtag aagccatgaa acagtatcag gaagaaattc aagaacttaa tgaagtcgcg 60
agacatcggc cacggtccac gttagttatg ggaatccagc aagaaaacag acaaatcaga 120
<210> 179
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 179
cagagagttg caacaagaaa acaaagaatt acgtacatct ctggaagaac atcagtcggc 60
cttggaactt ataatgagca agtaccgaga acaaatgttt agattgctaa tggctagcaa 120
<210> 180
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 180
gcaaaaaaga tgatccgggt ataataatga agttaaaaga gcagcactcc aagattgaca 60
tggtacatcg taacaagtcc gaaggattct tccttgatgc atctcgacac atccttgaag 120
<210> 181
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 181
gaaagtgcag ctgcagattt cagtgatgaa gatgaagatg atgatgttga tggaagagag 60
aaaagcgtca ttgatacttc aacaattgtt aggaaaaaag cattgcctga cagcggtgaa 120
<210> 182
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 182
gatcgagata caaaagaagc tctaaaggag tttgacttct tggttacatc agaggaagga 60
gacaatgaat ctagaagtgc aggcgatgga acagactggg aaaaggaaga ccagtgtctc 120
<210> 183
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 183
atgcctgaag cctggaatgt ggaccaggga gtaattacca aactcaagga acaatacaaa 60
aaggagagaa aggggaaaaa gggggtgaag aggcccaata ggtcaaaact acaagatatg 120
<210> 184
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 184
ggcgcgtcag gcaggagctg gaggataaga cagagcagct tgtggacacc agacatgagg 60
tggaccagct ggtgctggaa ctgcagaaag ttaagcagga gaacatccag ctagcggcag 120
<210> 185
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 185
agacgcccgg tctgctcgtg cctatcgaga cgagctggat tccctgcggg agaaggcgaa 60
ccgcgtggag aggctggagc tggagctgac ccgctgcaag gagaagctgc acgacgtgga 120
<210> 186
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 186
gacttctaca aggcccgcat ggaggagctg agagaagata atatcatttt aattgaaacc 60
aaggccatgc tggaggaaca gctgactgct gctcgggccc ggggcgataa agtccatgag 120
<210> 187
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 187
aggtgatgtg ctctatgaac tccttcagca tattctgaag cagaggaaac ctcggattct 60
tttttcacca ttcttccacc ctggaaactc tatacacaca cagccggagg tcatactgca 120
<210> 188
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 188
tcagaaccat gaagaagata actgtgtcca gaggaccccc aggccatccg tggataatgt 60
gcaccataac cctcccacca ttgaactgtt gcaccgctcc aggtcaccta tcacgacaaa 120
<210> 189
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 189
tcaccggcct tctcctgacc ccgagcagcg gcccctccgg tcccccctgg acaacatgat 60
ccgccgcctc tccccggctg agagagctca gggacccagg ccgcaccagg agaacaacca 120
<210> 190
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 190
ccaggagtcc taccctctgt cagtgtctcc catggagaat aatcactgcc cagcgtcctc 60
cgagtcccac ccgaagccat ccagcccccg gcaggagagc acacgcgtga tccagctgat 120
<210> 191
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 191
gcccagcccc atcatgcacc ctctgatcct gaacccccgg cactccgtgg atttcaaaca 60
gtccaggctc tccgaggacg ggctgcatag ggaagggaag cccatcaacc tctctcatcg 120
<210> 192
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 192
ggaagacctg gcttacatga accacatcat ggtctctgtc tccccgcctg aagagcacgc 60
catgcccatt gggagaatag cagactgtag actgctttgg gattacgtct atcagttgct 120
<210> 193
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 193
ttctgacagc cggtacgaaa acttcatccg atgggaggac aaagaatcca aaatattccg 60
gatagtggat cccaacggac tggctcgact gtggggaaac cataagaaca gaacaaacat 120
<210> 194
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 194
gacctatgag aaaatgtcca gagccctgcg ccactactac aaactaaaca ttatcaggaa 60
ggagccagga caaaggcttt tgttcaggtt tatgaaaacc ccagatgaaa tcatgagtgg 120
<210> 195
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 195
ccgaacagac cgtctggagc acctagagtc ccaggagctg gatgaacaaa tataccaaga 60
agatgaatgc tgaaggaacc aacagtccac ctcagcgggc cagcagccca gggaacccct 120
<210> 196
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 196
tgaagtctca tttgcagggt gagaagcaga aagccacaga ggccagtgct gtggagcaga 60
cggcagagag ctgcgaagtt caagaaatgt tgaaagtagc ccgagcagag aaagatctac 120
<210> 197
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 197
actggaactg tcttgcaatg agctcagaca agaattacta aaggcaaacg gtgaaattaa 60
acatgtttcc agtctgctgg ccaaggtgga aaaggattat tcatacctga aggagatatg 120
<210> 198
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 198
tgtgatcacc aagccgaaca gctgagcaga accagcctaa agctgcaaga aaaagcatca 60
gagagtgatg cagagatcaa agacatgaaa gaaaccatat ttgaattgga agatcaggtg 120
<210> 199
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 199
ggccaatcac tccctccagc tggcctcaca gatccagaag gcaccagacg tggccataga 60
ggtgctgacc cgctccagcc tagaagttga gttggccgcc aaggagcggg agatcgcaca 120
<210> 200
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 200
acagctggtg gaggacgtgc agagactcca ggccagcctc accaagctgc gggagaattc 60
ggccagccag atctcacagc ttgagcagca gctgagcgcc aaaaacagca cactcaaaca 120
<210> 201
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 201
acaactggaa gaaaaactca aaggccaggc tgactatgaa gaggtgaaga aagagctgaa 60
cattctgaag tccatggagt ttgcaccgtc cgagggcgct gggacacagg atgcggccaa 120
<210> 202
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 202
ggctgcgctg cagaccgggc agaggagcag cgccggcacc aagatgggct gccctacatt 60
gatgactcgc cctcctcatc gccccacctc agcagcaagg gcaggggcag ccgggatgcg 120
<210> 203
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 203
gctggtctcg ggagccctgg agtccactaa agcgagtgag ctggacttgg aaaagggctt 60
ggagatgaga aaatgggtcc tgtcgggaat cctggctagc gaggagactt acctgagcca 120
<210> 204
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 204
acctggaggc actgctgctg cccatgaagc ctttgaaagc cgctgccacc acctctcagc 60
cggtgctgac gagtcagcag atcgagacca tcttcttcaa agtgcctgag ctctacgaga 120
<210> 205
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 205
atccacaagg agttctatga tgggctcttc ccccgcgtgc agcagtggag ccaccagcag 60
cgggtgggcg acctcttcca gaagctggcc agccagctgg gtgtgtaccg ggccttcgtg 120
<210> 206
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 206
ctgaatgtca tcgtccactc agccactgga tttaagcaga gttcaaatct gtactgcacc 60
ctggaggtgg attcctttgg gtattttgtg aataaagcaa agacgcgcgt ctacagggac 120
<210> 207
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 207
cacagctgag ccaaactgga acgaggaatt tgagatagag ctggagggct cccagaccct 60
gaggatactg tgctatgaaa agtgttacaa caagacgaag atccccaagg aggacggcga 120
<210> 208
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 208
agagcacgga cagactcatg gggaagggcc aggtccagct ggacccgcag gccctgcagg 60
acagagactg gcagcgcacc gtcatcgcca tgaatgggat cgaagtaaag ctctcggtca 120
<210> 209
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 209
cagatctctg cactcgtcct aagagcccag gcctccgaga tcttacttga agagttacag 60
caggggcttt cccaggcaaa gagggatgtt caggaacaga tggcggtgct gatgcagtca 120
<210> 210
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 210
cacgggaaca ggtttcagaa gagctggtga ggttacagaa agataatgac agtctccagg 60
gaaagcacag cctgcatgtg tcattacagc aagcagaaga cttcatcctc ccagacacta 120
<210> 211
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 211
tacagaggca ctgcgggagt tggtattaaa ataccgtgag gacatcatta atgtgcggac 60
agcagcagac cacgtagaag aaaagctgaa ggctgagata cttttcctaa aagagcagat 120
<210> 212
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 212
gagcaagaaa aagtagagaa caaaactcct ttagttaatg agagcctgaa aaagttttta 60
aataccaaag acggtcgttt agtggctagt cttgttgcag aatttcttca gttttttaac 120
<210> 213
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 213
aaccttgact ttactttggc tgtttttcaa cctgaaacta gcacactgca aggtctcgaa 60
ggtcgagaga atttagcccg agatttaggt ataattgaag cagaaggtac tgtgggtgga 120
<210> 214
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 214
ggacccttat tattagaagt gatcaggcgc tgtcaacaga aagaaaaagg gccaaccact 60
ggggaaggtg cacttgatct atctgatgta cattctccac caaagtcacc agagggaaaa 120
<210> 215
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 215
aaaacaagtg cacagacaac accaagtaag ataccaaggt ataaaggaca aggtaagaag 60
aagacaagcg ggcagaaggc tggtgacaag aaggccaatg atgaggccaa tcagagtgat 120
<210> 216
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 216
gatacaagtg tctccttgtc agaacccaag agcaaaagca gccttcactt actgtcccat 60
gaaacaaaaa ttggatcttt tctaagcaac agaactttag atggcaaaga caaagctggc 120
<210> 217
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 217
acgacctgga aagagccaag cgcgccacga tcatgtctct cgaagacttt gagcagcgct 60
tgaatcaggc catcgaaaga aatgccttcc tggaaagtga acttgatgaa aaagagaatc 120
<210> 218
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 218
ctcctggaat ctgttcagag actgaaggat gaagccagag atttgcggca ggaactggcc 60
gtgcagcaga agcaggagaa acccaggacc cccatgccca gctcagtgga agctgagagg 120
<210> 219
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 219
gacagacaca gctgtgcagg ccacgggctc cgtgccgtcc acgcccattg ctcaccgagg 60
acccagctca agtttaaaca cacctgggag cttcagacgt ggcctggacg actccaccgg 120
<210> 220
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 220
ggatatgatg gaaaggcttt tggttcacct atgatcgatt tgagctcacc agtgggaggg 60
tcttataatc ttccctctct tccggatatt gactgttcaa gtactattat gctggacaat 120
<210> 221
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 221
atattgtgag gaaagatact aatatagatc atggccagcc aagaccaccc tcaaacagaa 60
cggtccagtc accaaattca tcagtgccat ctccaggcct tgcaggacct gttactatga 120
<210> 222
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 222
gactagtgta caccccccaa tacgttcacc tagtgcctcc agcgttggaa gccgaggaag 60
ctctggctct tccagcaaac cagcaggagc tgactctaca cacaaagtcc cagtggtcat 120
<210> 223
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 223
acaggacctc cgaaaccaac acaccacagg gaaaccagga acaactggta actgtcatgg 60
aggaacgaat gatagaagtt gaacagaaac tgaaactagt gaaaaggctt cttcaagaga 120
<210> 224
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 224
aagtgaatca gctcaaagaa caactctgca agaacactaa ggcagacgca atggtgaagg 60
acttgtatgt tgaaaatgcc cagttgttga aagctctgga agtgactgaa cagcgacaga 120
<210> 225
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 225
aaacagcaga gaagaaaaat tacctcctgg aggagaagat tgccagcctc agtaatatag 60
ttaggaatct gacaccagcg ccattgactt ctacacctcc tttgaggtca tagccaaacc 120
<210> 226
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 226
cccctactgc ctccagtagc agcagcacaa cccctacccg aaagatcaca gaaagtcctc 60
gtgcctccat gggagttctc tcaggcaaaa gaaaacttat cacttctgaa gaggaacggt 120
<210> 227
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 227
cccctgccaa gcgaggtcgc aagtctgcca cagtaaaacc tggtgcagta ggggcaggag 60
agtttgtgag cccctgtgag agtggagaca acaccggtga accctctgcc ctggaagagc 120
<210> 228
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 228
agagagggcc tttgcctctc aacaagacct tgtttctggg ctacgcattt ctccttacca 60
tggccacaac cagtgacaag ttggccagcc gctccaaact gccagatggt cctacaggaa 120
<210> 229
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 229
ctaagcataa ctaaaggtga aaagctccgg gtcttaggct ataatcacaa tggggaatgg 60
tgtgaagccc aaaccaaaaa tggccaaggc tgggtcccaa gcaactacat cacgccagtc 120
<210> 230
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 230
aacagtctgg agaaacactc ctggtaccat gggcctgtgt cccgcaatgc cgctgagtat 60
ctgctgagca gcgggatcaa tggcagcttc ttggtgcgtg agagtgagag cagtcctggc 120
<210> 231
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 231
cagaggtcca tctcgctgag atacgaaggg agggtgtacc attacaggat caacactgct 60
tctgatggca agctctacgt ctcctccgag agccgcttca acaccctggc cgagttggtt 120
<210> 232
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 232
catcatcatt caacggtggc cgacgggctc atcaccacgc tccattatcc agccccaaag 60
cgcaacaagc ccactgtcta tggtgtgtcc cccaactacg acaagtggga gatggaacgc 120
<210> 233
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 233
acggacatca ccatgaagca caagctgggc gggggccagt acggggaggt gtacgagggc 60
gtgtggaaga aatacagcct gacggtggcc gtgaagacct tgaaggagga caccatggag 120
<210> 234
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 234
gtggaagagt tcttgaaaga agctgcagtc atgaaagaga tcaaacaccc taacctggtg 60
cagctccttg gggtctgcac ccgggagccc ccgttctata tcatcactga gttcatgacc 120
<210> 235
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 235
tacgggaacc tcctggacta cctgagggag tgcaaccggc aggaggtgaa cgccgtggtg 60
ctgctgtaca tggccactca gatctcgtca gccatggagt acctggagaa gaaaaacttc 120
<210> 236
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 236
tgaatctagg cggcagtacg aagagaaaaa caaagaattt gaaagggaaa aacacgccca 60
cagtatactg caatttcagt ttgctgaagt caaggaggcc ctgaagcaaa gagaggaaat 120
<210> 237
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 237
gctcgagaaa catggaataa tcctaaattc agaaatagct accaatggag agacttccga 60
caccctcaat aatgttggat accaaggtcc taccaagatg acaaaagaag agttaaatgc 120
<210> 238
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 238
cctcaagtcg acaggggatg ggaccctagg aagagccagt gaagtggagg tgaaaaatga 60
aatcgtggcg aatgtgggga aaagagaaat cttgcacaat actgagaaag aacaacacac 120
<210> 239
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 239
ttgtacagac ctaagaaacc ctgacattcg ggtgctaatt tgtgaagaaa aagcaccagt 60
tctcaagatg gagcttgata gatcagctga tcctcctcct gcaatttggg ttgcaacaac 120
<210> 240
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 240
taagtctaca gtaaataaat ggactttgaa aggaattcat aattttagag cctctggaga 60
ttatgacaat gactgtacaa atcctataac acctctttgt acacaacctg accaggttat 120
<210> 241
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 241
taaagggggt gctagtatta ttcagtgcca cattcttaat gataagagac atatattaac 60
caaagatacc aataataatg tggcatattg ggatgtattg aaggcatgta aagttgaaga 120
<210> 242
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 242
acctttaaca atgacaaaag ctacttactg taaacctcac atgcagacca aatcttgtca 60
gacagatgat acttggagga cagaatatgt tccagtgcct atccctgtgc ctgtgtatat 120
<210> 243
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 243
tcccagttcc tatgcacatg tacagtcaga atattcctgt tcctactaca gttcctgttc 60
ctgtgccagt tcctgttttt ctgcctgctc cattggacag cagtgagaag attcctgcag 120
<210> 244
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 244
gcaattgagg agctaaaaag caaggtttct tcagatgctc ttgatacaga gttgcttaca 60
atgacggata tgatgagtga agacgagggg aaaacagaga caaccaacat caacagtgta 120
<210> 245
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 245
aggcgacggg caaatgagaa cagcaacata caggtccttt ctgaaagatc tgctactgaa 60
gtagacaaca attttagcaa accacctccg tttttccctc caggagctcc tcccactcac 120
<210> 246
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 246
caccttccac ctcctccatt tcttccacct cctccgactg tcagcactgc tccacctctg 60
attccaccac cgggttttcc tcctccacca ggcgctccac ctccatctct tataccaaca 120
<210> 247
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 247
acaatagaaa gtggacattc ctctggttat gatagtcgtt ctgcacgtgc atttccatat 60
ggcaatgttg cctttcccca tcttcctggt tctgctcctt cgtggcctag tcttgtggac 120
<210> 248
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 248
gacaccagca agcagtggga ctattatgcc agaagagaga aagaccgaga tagagagaga 60
gacagagaca gagagcgaga ccgtgatcgg gacagagaaa gagaacgcac cagagagaga 120
<210> 249
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 249
agagagaggg agcgtgatca cagtcctaca ccaagtgttt tcaacagcga tgaagaacga 60
tacagataca gggaatatgc agaaagaggt tatgagcgtc acagagcaag tcgagaaaaa 120
<210> 250
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 250
aaagaagaac gacatagaga aagacgacac agggagaaag aggaaaccag acataagtct 60
tctcgaagta atagtagacg tcgccatgaa agtgaagaag gagatagtca caggagacac 120
<210> 251
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 251
ccagtgctgg tgattatggg agtgctattg agacactggt aactgcaatt tctttaatta 60
aacaatccaa agtatctgct gatgatcgtt gcaaagttct tattagttct ttgcaagatt 120
<210> 252
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 252
ttgccttcat ggaattgagt ccaagtctta tggttctgga tcaagacgtg aacgatcaag 60
agagagggac catagtagat cacgagaaaa gagtcgacgt cataaatccc gtagtagaga 120
<210> 253
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 253
gaccgtcatg acgattatta cagagagaga agcagagaac gagagaggca ccgggatcgt 60
gaccgagacc gtgaccgaga gcgtgaccga gagcgcgaat atcgtcatcg ttagaagctg 120
<210> 254
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 254
aagctctgca agaacaactg gatgaaagac ttcaagaact agaaaagata aaggaccttc 60
atatggccga gaagactaaa cttatcactc agttgcgtga tgcaaagaac ttaattgaac 120
<210> 255
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 255
cagcttgaac aagataaggg aatggtaatc gcagagacaa aacgtcagat gcatgaaacc 60
ctggaaatga aagaagaaga aattgctcaa ctccgtagtc gcatcaaaca gatgactacc 120
<210> 256
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 256
ccagggagag gaattacggg aacagaaaga aaagtccgaa agagctgctt ttgaggaact 60
tgaaaaagct ttgagtacag cccaaaaaac agaggaagca cggagaaaac tgaaggcaga 120
<210> 257
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 257
cccatgagtt tgccacgctg gtcattgaca ttctcagtga cgccaagagg agacagcagg 60
gcagttctct ctcgggttca aaagacaatg tggagctcat actgaaaacc atcaataacc 120
<210> 258
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 258
ccagcacagc gttgagagtc aagacaacga tcagcccgac tatgacagcg tggcatcaga 60
cgaagacaca gatttggaaa ccactgcaag caaaacaaac cggcagaaga gcctagattc 120
<210> 259
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 259
tcagatttat cagatggacc agtcactgta caggaattta tggaggtcaa aaacgctcta 60
gtggcttctg aggccaagat acagcagcta atgaaggtga ataacaactt gagtgacgag 120
<210> 260
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 260
cttcattgtc gttttaaccc tgctaatttg tcacaagtac aaaaagcaat ttaggtatga 60
aagccagcta cagatggtac aggtgaccgg ctcctcagat aatgagtact tctacgttga 120
<210> 261
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 261
ttgatttcag agaatatgaa tatgatctca aatgggagtt tccaagagaa aatttagagt 60
ttgggaaggt actaggatca ggtgcttttg gaaaagtgat gaacgcaaca gcttatggaa 120
<210> 262
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 262
ggaattagca aaacaggagt ctcaatccag gttgccgtca aaatgctgaa agaaaaagca 60
gacagctctg aaagagaggc actcatgtca gaactcaaga tgatgaccca gctgggaagc 120
<210> 263
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 263
ggcagatagg aagtatgaag aggtggctcg taagttggtg atcattgaag gagacttgga 60
acgcacagag gaacgagctg agctggcaga gtctaagtgt tctgagctgg aggaggagct 120
<210> 264
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 264
ctgaagaatg tcaccaacaa cctcaagtct cttgaggctc aggcggagaa gtactctcaa 60
aaagaagata aatatgagga agaaatcaag attcttactg ataaactcaa ggaggcagag 120
<210> 265
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 265
agacccgtgc tgagtttgct gagagatcgg tagccaagct ggaaaagaca attgatgacc 60
tggaagatga gctctatgcc cagaaactga agtacaaggc cattagcgag gagctggacc 120
<210> 266
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 266
cgccaatatt taggagggag agactccctg atgtcccaag cacccatctc taaccaacaa 60
gctgaagtta cccccactgg ccgtcttgga aaacagactg atcaaggttc aatgcagata 120
<210> 267
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 267
taccttccag agatgatagc acttcattga ctgccaaaga ggatgtcagc atacccagat 60
ccacattagg agacttggac acagttgcag ggctggaaaa agaactgagt aatgccaaag 120
<210> 268
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 268
agaggaactt gaactcatgg ctaaaaaaga aagagaaagt cagatggaac tttctgctct 60
acagtccatg atggctgtgc aggaagaaga gctgcaggtg caggctgctg atatggagtc 120
<210> 269
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 269
ggccaatcac tccctccagc tggcctcaca gatccagaag gcaccagacg tggccataga 60
ggtgctgacc cgctccagcc tagaagttga gttggccgcc aaggagcggg agatcgcaca 120
<210> 270
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 270
acagctggtg gaggacgtgc agagactcca ggccagcctc accaagctgc gggagaattc 60
ggccagccag atctcacagc ttgagcagca gctgagcgcc aaaaacagca cactcaaaca 120
<210> 271
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 271
acaactggaa gaaaaactca aaggccaggc tgactatgaa gaggtgaaga aagagctgaa 60
cattctgaag tccatggagt ttgcaccgtc cgagggcgct gggacacagg atgcggccaa 120
<210> 272
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 272
aagaaagtga gacactgaca gaacaggatt tacagttata ttgcgatttt cctaatatta 60
ttgatgtcag tattaagcaa gcaaaccaag agggttcaaa tgaaagccga gttgtaacta 120
<210> 273
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 273
ctatccataa gcaagatggt aaaaatctgg aaattgaact tagctcatta agggaagctt 60
tgtctttcgt gtcattaatt gatggatatt atagattaac tgcagatgca catcattacc 120
<210> 274
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 274
acctctgtaa agaagtagca cctccagccg tgcttgaaaa tatacaaagc aactgtcatg 60
gcccaatttc gatggatttt gccattagta aactgaagaa agcaggtaat cagactggac 120
<210> 275
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 275
gactgtatgt acttcgatgc agtcctaagg actttaataa atattttttg acttttgctg 60
tcgagcgaga aaatgtcatt gaatataaac actgtttgat tacaaaaaat gagaatgaag 120
<210> 276
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 276
aagagtacaa cctcagtggg acaaagaaga acttcagcag tcttaaagat cttttgaatt 60
gttaccagat ggaaactgtt cgctcagaca atataatttt ccagtttact aaatgctgtc 120
<210> 277
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 277
gtcccccaaa gccaaaagat aaatcaaacc ttctagtctt cagaacgaat ggtgtttctg 60
atgtaccaac ctcaccaaca ttacagaggc ctactcatat gaaccaaatg gtgtttcaca 120
<210> 278
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 278
acaaaatcag aaatgaagat ttgatattta atgaaagcct tggccaaggc acttttacaa 60
agatttttaa aggcgtacga agagaagtag gagactacgg tcaactgcat gaaacagaag 120
<210> 279
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 279
aagttctttt aaaagttctg gataaagcac acagaaacta ttcagagtct ttctttgaag 60
cagcaagtat gatgagcaag ctttctcaca agcatttggt tttaaattat ggagtatgtg 120
<210> 280
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 280
gtgtctgtgg agacgagaat attctggttc aggagtttgt aaaatttgga tcactagata 60
catatctgaa aaagaataaa aattgtataa atatattatg gaaacttgaa gttgctaaac 120
<210> 281
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 281
aacagttggc atgggccatg cattttctag aagaaaacac ccttattcat gggaatgtat 60
gtgccaaaaa tattctgctt atcagagaag aagacaggaa gacaggaaat cctcctttca 120
<210> 282
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 282
tcatcaaact tagtgatcct ggcattagta ttacagtttt gccaaaggac attcttcagg 60
agagaatacc atgggtacca cctgaatgca ttgaaaatcc taaaaattta aatttggcaa 120
<210> 283
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 283
caacagacaa atggagtttt ggtaccactt tgtgggaaat ctgcagtgga ggagataaac 60
ctctaagtgc tctggattct caaagaaagc tacaatttta tgaagatagg catcagcttc 120
<210> 284
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 284
ttcctgcacc aaagtgggca gaattagcaa accttataaa taattgtatg gattatgaac 60
cagatttcag gccttctttc agagccatca tacgagatct taacagtttg tttactccag 120
<210> 285
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 285
cagattatga actattaaca gaaaatgaca tgttaccaaa tatgaggata ggtgccctgg 60
ggttttctgg tgcctttgaa gaccgggatc ctacacagtt tgaagagaga catttgaaat 120
<210> 286
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 286
aatttctaca gcaacttggc aagggtaatt ttgggagtgt ggagatgtgc cggtatgacc 60
ctctacagga caacactggg gaggtggtcg ctgtaaaaaa gcttcagcat agtactgaag 120
<210> 287
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 287
gcccaccagg attgctggaa gtgtgacgga gcaggcgggc tgaggagagt ggaaaaggaa 60
gcgacccaga aatggcaggg acacttctct tgcagaccaa gagggaccct ggagcacctt 120
<210> 288
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 288
attaaaaaat gctcaaaaag aaattgccac attgaaacag cacctcagta atatggaagt 60
ccaagttgct tctcagtctt cacagagaac tggtaaaggt cagcctagca acaaagaaga 120
<210> 289
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 289
atgtggatga tcttgtgagt cagctaagac agacagaaga gcaggtgaat gacttaaagg 60
agagactcaa aacaagtacg agcaatgtgg aacaatatca agcaatggtt actagtttag 120
<210> 290
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 290
gaagaatccc tgaacaagga aaaacaggtg acagaagaag tgcgtaagaa tattgaagtt 60
cgtttaaaag agtcagctga atttcagaca cagttggaaa agaagttgat ggaagtagag 120
<210> 291
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 291
ggaagcactg gtcgaagagt gtgatggaca aacagtacga gattctgtgt gtcagccagt 60
ttaccctcca gtgtgtcctg aagggaaaca agcctgattt ccacctagca atgcccacgg 120
<210> 292
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 292
cccacggagc aggcagaggg cttctacaac agcttcctgg agcagctgcg taaaacatac 60
aggccggagc ttatcaaaga tggcaagttt ggggcctaca tgcaggtgca cattcagaat 120
<210> 293
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 293
tcagaatgat gggcctgtga ccatagagct ggaatcgcca gctcccggca ctgctacctc 60
tgacccaaag cagctgtcaa agctcgaaaa acagcagcag aggaaagaaa agaccagagc 120
<210> 294
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 294
atgaagtgaa tgaaagagag aaagcaatgg aaaatcgtta caagagtctt ctgagtgaaa 60
gcaataaaaa attgcacaat caagagcaag tgatcaaaca tctaacagaa agtaccaatc 120
<210> 295
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 295
tcagaaggac gtgttgcttc agaaattcaa tgaaaaagat ttggaagtaa tacagcagaa 60
ctgctattta atggctgcag aggatcttga gctcaggagt gaaggcttaa taacagaaaa 120
<210> 296
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 296
aagtgctctt ctcaacagcc accaggcagc aaaaccatct tctctaagga aaagaaacaa 60
tcatcagact atgaagagct gattcaggtc ttaaagaaag agcaggacat ctatacccat 120
<210> 297
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 297
cctccgtgga aacaaacagt gtaggcatct cctgccagcc tgaatgtaag aataaagtcg 60
tagggcctga gctgcctatg aattggtgga ttgttaagga gagggtggaa atgcatgacc 120
<210> 298
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 298
cgatgtgctg ggaggtctgt ggaaatgtgt gacaagagtg tgagtgtgga agtcagcgtc 60
tgcgaaacag gcagcaacac agaggagtct gtgaacgacc tcacactcct caagacaaac 120
<210> 299
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 299
cttgaatctc aaagaagtgc ggtctatcgg ttgtggagat tgttctgttg acgtgaccgt 60
ctgctctcca aaggagtgcg cctcccgggg cgtgaacact gaggctgtta gccaggtgga 120
<210> 300
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 300
cagtggcaaa agaacttcag actttacaca acctgcgcaa actctttgtt caggacctgg 60
ctacaagagt taaaaagagt gctgagattg attctgatga caccggaggc agcgctgctc 120
<210> 301
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 301
tcagaagcaa aaaatctcct ttcttgaaaa taatcttgaa cagctcacta aagtgcacaa 60
acagttggta cgtgataatg cagatctccg ctgtgaactt cctaagttgg aaaagcgact 120
<210> 302
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 302
cttcgagcta cagctgagag agtgaaagct ttggaatcag cactgaaaga agctaaagaa 60
aatgcatctc gtgatcgcaa acgctatcag caagaagtag atcgcataaa ggaagcagtc 120
<210> 303
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 303
ataatctcag acaacaaaat gagactgcta gtaagataat agacagccaa caagatgaga 60
ttgacagaat gattttagaa attcagtcta tgcaaggaaa gctttctaaa gagaaactga 120
<210> 304
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 304
accactcaaa agatgatgga agagctggaa aagaaagaaa gaaatgtaca gagattaaca 60
aaagcattgc ttgaaaacca aagacaaaca gatgagacat gctctttatt ggatcagggc 120
<210> 305
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 305
ccaggaacct gaccaatcta ggcagcagac agttctttcc aaacggccac tatttgattt 60
gactgtgatt gatcagctgt tcaaggaaat gtcctgttgt ttgtttgact tgaaagcatt 120
<210> 306
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 306
ggtagcccag gacaaccatg agcgggccag gcgcctgatg aaggagctca accagatgca 60
gtatgagtac acggagctca agaaacagat ggcaaaccaa aaagatttgg agagaagaca 120
<210> 307
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 307
aatggaaatc agtgatgcaa tgaggacact taaatctgag gtgaaggatg aaatcagaac 60
cagcttgaag aatcttaatc agtttcttcc agaactacca gcagatctag aagctatttt 120
<210> 308
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 308
ggaaagaaac gaaaacctag aaggagaatt ggaaagcttg aaagagaacc ttccatttac 60
catgaatgag ggaccttttg aagaaaaact gaacttttcc caagttcaca taatggatga 120
<210> 309
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 309
acactggcgt ggagaagcac tccgggagaa actgcgtcac cgggaagacc gactcaaggc 60
ccaactccga cactgtatgt ccaagcaagc agaagtatta attaaaggaa agcggcagac 120
<210> 310
<211> 120
<212> DNA
<213> Artificial Synthesis
<400> 310
agagggcact ttacacagtt tgaggagaca agtagatgct ttaggggaat tggtcaccag 60
cacctctgca gattcagcgt catcacccag tctgtctcag ctggagtctt ccctcacaga 120

Claims (8)

1. A detection probe composition of a clonal eosinophilia-mediated disease fusion gene, wherein a target gene of the detection probe composition comprises a class I gene and a class II gene;
the target region of the detection probe composition is the full length of the transcript of the class I gene and the region within 100-300 bp near the fusion breakpoint of the class II gene;
the class I genes include FGFR1, PDGFRA and PDGFRB;
the class II genes include ABL1, BCR, CCDC88C, CDK5RAP2, CEP110, CEP85L, CPSF6, CUX1, DTD1, ETV6, FGFR1OP1, FGFR1OP2, FIP1L1, FLT3, GIT2, GOLGA4, HIP1, JAK2, KANK1, KIF5B, LRRFIP1, MYO18A, NDE1, NIN, PCM1, PDE4DIP, PRKG2, RABEP1, cc1, STRN, TPM3, TPR, TP53BP1, TRIM24, WDR48, and ZNF 198.
2. The detection probe composition of claim 1, wherein the fusion gene detected by the detection probe composition comprises: PCM1-JAK2, ETV6-JAK2, BCR-JAK2, ETV6-ABL 6, ETV6-FLT 6, ETV6-PDGFRA, FIP1L 6-PDGFRA, KIF5 6-PDGFRA, CDK5RAP 6-PDGFRA, STRN-PDGFRA, BCR-PDGFRA, ETV6-PDGFRB, WDR 6-PDGFRB, TPM 6-PDGFRB, MYO18 6-PDGFRB, PDE4DIP-PDGFRB, PRKG 6-PDGFRB, GOLGA 6-PDGFRB, HIP 6-PDGFRB, GIT 6-PDGFRB, NIN-PDGFRB, HIP 3653 BP 6-FRB, NDE 6-PDGB, RABEBEP 6-PDGFRB, RABEP 6-PDGFRB, PDGFR72-PDGFRB, PDGFRC 6-PDGFRB, PDGFR72-6-PDGFRB, PDGFRF 6-PDGFRB, PDGFRF 6-FGFR-6, PDGFR72-6, PDGFRB, PDGFRF 6-FGFR-6, PDGFRB, PDGFR72-6-FGFR-6, PDGFRB, PDGFR72-6-FGFR-6, PDGFRFGFR-6, PDGF-6, PDGFRFGFR-6, PDGFRFGFR-6, PDGF-6, PDGFRFGFR-6, PDGFRFGFR-6, PDGF-6, PDGFRB, PDGF-6, PDGFRFGFR-6, PDGF-FGFR-6, PDGFRFGFR-6, PDGF-6, PDGFRFGFR-6, PDGFRB, PDGFRFGFR-6, PDGFRFGFR-6, PDGF-6, FGFR-6, PDGF-6, PDGFRFGFR-6, PDGFR72-6, PDGFRFGFR-6, PDGFRFGFR-6, PDGF-6, PDGFRFGFR-6, FGFR-6, PDGFRFGFR-6, PDGF-6, PDGFR72, PDGF-6, FGFR-6, PDGFRB, FGFR-6.
3. The detection probe composition according to claim 1, wherein the detection probe composition comprises a nucleic acid sequence as set forth in SEQ ID No. 1-310;
and the probe in the detection probe composition modifies a marker molecule I, and the marker molecule I comprises biotin.
4. A kit for detecting a clonal eosinophilia fusion gene, comprising the detection probe composition of any of claims 1 to 3;
the detection kit also comprises any one or the combination of at least two of a reverse transcription reagent, a sequencing library construction reagent, a PCR reagent or a probe hybridization reagent.
5. The test kit according to claim 4, wherein the reverse transcription reagent comprises a single-stranded cDNA synthetase and/or a double-stranded cDNA synthetase;
the sequencing library construction reagent comprises any one or combination of at least two of RNA fragmentation enzyme, tail-end-added A-tailing enzyme, ligase or linker;
the PCR reagent comprises DNA polymerase and/or PCR primer;
the probe hybridization reagent comprises a hybridization buffer and/or an RNase inhibitor.
6. The test kit according to claim 4 or 5, wherein the test kit further comprises nucleic acid purification reagents;
the nucleic acid purification reagent comprises magnetic beads and/or a cleaning solution;
the magnetic beads modify marker molecules II, and the marker molecules II comprise streptavidin;
the label molecule II is combined with the label molecule I carried by the probe in the detection probe composition.
7. A device for detecting a clonal eosinophilia fusion gene, said device comprising:
a nucleic acid extraction module: for extracting RNA from a clonal eosinophilia sample;
a reverse transcription module: for reverse transcription of the extracted RNA into cDNA;
pre-library construction module: the method is used for carrying out terminal repair, A tail addition, linker connection and PCR amplification on the reverse transcription cDNA to construct a pre-library;
a hybrid capture module: a method for capturing a target fragment from a pre-library by using the detection probe composition of any one of claims 1 to 3, and performing PCR amplification to construct a probe capture library;
a sequencing module: for sequencing and data processing of the probe capture library.
8. Use of the detection probe composition of any one of claims 1 to 3, the detection kit of any one of claims 4 to 6 or the detection device of claim 7 for the preparation of a diagnostic product for clonal hypereosinophilia.
CN202110754789.XA 2021-07-05 2021-07-05 Clonal eosinophilia hypereosinophilia fusion gene detection probe composition, kit and application thereof Active CN113249469B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110754789.XA CN113249469B (en) 2021-07-05 2021-07-05 Clonal eosinophilia hypereosinophilia fusion gene detection probe composition, kit and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110754789.XA CN113249469B (en) 2021-07-05 2021-07-05 Clonal eosinophilia hypereosinophilia fusion gene detection probe composition, kit and application thereof

Publications (2)

Publication Number Publication Date
CN113249469A true CN113249469A (en) 2021-08-13
CN113249469B CN113249469B (en) 2021-10-15

Family

ID=77190634

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110754789.XA Active CN113249469B (en) 2021-07-05 2021-07-05 Clonal eosinophilia hypereosinophilia fusion gene detection probe composition, kit and application thereof

Country Status (1)

Country Link
CN (1) CN113249469B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115083516A (en) * 2022-07-13 2022-09-20 北京先声医学检验实验室有限公司 Panel design and evaluation method for detecting gene fusion based on targeted RNA sequencing technology

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112662771A (en) * 2020-12-30 2021-04-16 苏州大学附属第一医院 Targeting capture probe of tumor fusion gene and application thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112662771A (en) * 2020-12-30 2021-04-16 苏州大学附属第一医院 Targeting capture probe of tumor fusion gene and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AARONT.GERDS等: "Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021", 《JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK》 *
N.SAVAGE等: "Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review", 《INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY》 *
NICOLE NAUMANN等: "Fusion of PDGFRB to MPRIP, CPSF6, and GOLGB1 in Three Patients with Eosinophilia-Associated Myeloproliferative Neoplasms", 《GENE,CHROMOSOMES&CANCER》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115083516A (en) * 2022-07-13 2022-09-20 北京先声医学检验实验室有限公司 Panel design and evaluation method for detecting gene fusion based on targeted RNA sequencing technology

Also Published As

Publication number Publication date
CN113249469B (en) 2021-10-15

Similar Documents

Publication Publication Date Title
KR101446626B1 (en) Composition and method for diagnosing kidney cancer and for predicting prognosis for kidney cancer patient
CN109423515B (en) Gene markers for liver cancer detection and application thereof
CN111979307B (en) Targeted sequencing method for detecting gene fusion
CN109837273A (en) A kind of CRISPR assists DNA target to enrichment method and its application
CN110628894A (en) Targeted capture sequencing kit for Parkinson&#39;s disease gene mutation detection and application thereof
CN111334573A (en) Gene detection kit for hypertension medication and use method
CN106636344A (en) Thalassemia gene detection kit based on next generation high-throughput sequencing technology
CN113249469B (en) Clonal eosinophilia hypereosinophilia fusion gene detection probe composition, kit and application thereof
CN108085387B (en) Specific capture probe, kit and sequencing library for detecting human BRCA1/2 gene mutation and construction method thereof
CN109628573B (en) Kit for noninvasive prenatal detection of 12 chromosome microdeletion and microduplication syndrome and special probe set thereof
CN110218797A (en) FGFR Gene Fusion probe, detection method and kit
CN111575379B (en) Kit for detecting 58 genes related to thyroid cancer and using method thereof
CN112391466A (en) Methylation biomarker for detecting breast cancer or combination and application thereof
US20030219805A1 (en) Detection of alternative and aberrant mRNA splicing
CN112029771A (en) Aptamer specifically binding to meperidine and application thereof
CN110541031A (en) Method for in vitro diagnosis or prognosis of ovarian cancer
CN111440856A (en) Probe set and kit for detecting related pathogenic genes of methylmalonic acidemia
CN113215237B (en) Synchronous detection kit and method for HPA and HLA antigen system
CN110904212B (en) Kit for capturing related gene of sexual dysplasia and application thereof
CN111394446A (en) Kit for detecting phenylketonuria related pathogenic gene and special capture probe set thereof
CN114032298B (en) Probe set for detecting genetic bilirubin metabolic abnormality and intrahepatic cholestasis related gene variation, kit and application thereof
CN116445478B (en) Primer combination for constructing IGHV gene library and application thereof
CN113403404B (en) circRNA, product and application thereof
KR102480124B1 (en) Single nucleotide polymorphisms associated with reproduction of African indicine breeds and their application
KR102513462B1 (en) Composition for detecting Inherited Blood Coagulation Disorders and use thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant